Volume 11, Issue 1

PO BOX 2549 • FAIRFAX, VIRGINIA 22031-0549
Winter 2008 • Volume 11 Number 1
Transition of Authority for a Deployed Laboratory
MAJ Paul Mann1 and CPT Victoria McCarthy2
AMEDD Center & School, FT Sam Houston, Texas, 286th Combat Support Hospital, Baghdad, Iraq
1
As military scientists and leaders, many of us have experienced the challenges of adjusting to a new assignment.
Permanent Change of Station moves are a part of military life. We have all faced this trial in the past and will again in
the future. Succeeding at a new assignment is always a challenge. Understanding the mission of a new organization, and
learning the techniques, technologies, instrumentation, and policies in a new laboratory are challenges that all of us, as
scientists and leaders, will face. Similarly, with each new assignment comes the challenge of meeting and working with new
personnel. Fortunately, in most laboratories there is a core group of civilian employees, with minimal turnover, that serve
as a source of institutional knowledge and stability. Additionally, in any given year, typically only 25-30 percent of a unit’s
military personnel will turn over. Thus the difficulties involved with personnel turnovers are minimized.
Deployments present different challenges for laboratory leaders that assignments to standard military health care
facilities will rarely offer. Often entire units are replaced in a very short time. Such was the case when the 86th Combat
Support Hospital (CSH) replaced the 28th CSH at Ibn Sina Hospital in Baghdad’s International Zone. Imagine assuming
the leadership position in a deployed clinical laboratory that supports a medical facility treating severe combat injuries with
a monthly workload that approaches that of many large CONUS MEDDACs (“medical activities,” or Army hospitals).
Additionally, the laboratory issues over 1,000 blood products a month, maintains a vigorous platelet apheresis program,
and has a full microbiology mission. Assuming leadership at a time when the entire laboratory staff is also turning over in
a major trauma facility is a position few will ever face. This is the situation that occurs on a yearly basis in deployed Army
Combat Support Hospitals where the transition of authority takes place in just a week and is the very challenge faced by the
OIC of the 86th CSH laboratory.
Normally, when new personnel are assigned to a clinical lab, there is an established process of training and orientation.
It requires that technicians and technologists master different instrumentation, learn pertinent test kits, become skilled at new
techniques, and study new SOPs. This process is not unfamiliar to military lab techs, who often rotate assignments several
times during a career. It’s all part of orientation and initial competency assessment, a process that normally takes several
weeks in a CONUS-based laboratory. However, when a CSH rotates, the entire laboratory staff must navigate through this
process in approximately one week. Successfully overcoming the difficulties associated with this changeover requires a
Con’t on page 6 - Transition of Authority
In This Issue...
2
4
5
8
9
10
11
12
13
14
Editor’s Page
President’s Message
Consultant’s Corner
Call for Nominations
Hotel Information
President’s Reception
Fun Run
SAFMLS 2008 Schedule
CEU Credit Hours
Workshops & Room Assignments
28
46
47
55
59
60
64
65
67
68
Short Topics & Room Assignments
Short Topics “At-A-Glance”
2008 SAFMLS Posters
Hotel Layouts
Vendor List
Constitution & Bylaws
Guess the Unknown
Membership Application
2007-2008 Board Of Directors
Calendar
Society Scope
Society of Armed Forces
Medical Laboratory Scientists
Board of Directors
President: LTC Kevin M. McNabb, USA
Vice-President: CDR Larry Ciolorito, USN
Treasurer: Maj Marybeth Luna, USAF
Secretary: CDR Chris Howe, USN
President-Elect: Lt Col Brian Casleton, USAF
Past President: CDR Cindy Wilkerson, USN
Members-at-Large:
MAJ Paul Mann, USA
CPT Gerald Kellar, USA
LT Aaron Harding, USN
LT Deb Baker, USN
Maj Richard Schoske, USAF
Capt Denise Lennon, USAF
MSgt David Beacham, USAF
Ex-Officio Members:
COL William Boisvert, USA
COL Mark Brissette, USA
CDR Larry Ciolorito, USN
CDR Dave Larson, USN
Col Paul Barnicott, USAF
LtCol Dale Selby, USAF
Chairman, Exhibits/Site Selection
LtCol Bailey Mapp, USAF
Historian: LTC Dan Deuter, USA
Web Master: CAPT Michael Finch, USN
Newsletter Staff
Editor: Maj Jeannette M. Watterson, USAF
[email protected]
Office (937) 257-9362 DSN 787-9362
Happy 2008! This issue of the Scope preps us for our
upcoming meeting. By the time you receive this, on-line registration
should be available at www.safmls.org. Also, be sure get your hotel
reservations if you have not already done so.
Inside you’ll find a schedule of events to plan your week, as well
as the workshop, short topic, and poster offerings. There are also
instructions on earning continuing medical education hours through
PACE. This year’s Fun Run will be held on Wednesday morning,
and the vendors’ exhibit will be on Tuesday and Wednesday, as
always. Please spend some time visiting with the vendors, as they
help fund a significant portion of our meeting.
Also in this issue is a draft of proposed changes to the SAFMLS
Bylaws. The change deals with making the PACE coordinator a
non-voting board member, and will be voted on at the business
meeting on Monday morning. We will also be electing new officers
for 2009.
Good luck with your planning, have a safe trip, and see you in
Nawlins!
Maj Jeannette M. Watterson, USAF
SOCIETY SCOPE is published three times per
year for $30 (nonmember rate) by the Society
of Armed Forces Medical Laboratory Scientists (SAFMLS). Send SCOPE correspondence
to 9301 Blueberry Drive, Ocean Springs, MS
39564. Annual dues ($15) for SAFMLS membership and address changes should be sent to
CDR Christine Howe, SAFMLS Secretary, 804
Wakedale Arch, Chesapeake, VA 23322
Advertising rates:
Display ads - ½ page ad, $400
¼ page ad, $200
Ads should be sent to:
PS design & type,
4491 Cheshire Station Plaza #154
Dale City, Virginia 22193
Voice: 703-583-4303
Fax: 703-670-2929
e-mail: [email protected]
2
New Deadlines for SAFMLS Society Scope:
Winter
Summer
Fall
Vol X Number 1
Vol X Number 2
Vol X Number 3
Deadline: 1 Dec
Deadline: 1 Apr
Deadline: 1 Aug
Society Scope
President’s Message
LTC Kevin M. McNabb, USA
Well, depending upon when this gets to you, Happy New Year! What a great year 2007 was and it went so quickly it
was difficult to keep up. With the annual meeting just around the corner in February, the Planning Committee has been busy
with the many things that must be completed to get our meeting ready to go. The 2008 meeting, at the Hilton Riverside in
New Orleans promises to be another outstanding event.
I would like to thank CDR Larry Ciolorito and the
entire Planning Committee for all their hard work. With
the early meeting this year, the task of getting meeting
ready has been a bigger challenge than usual. I would
also like to thank LtCol Bailey Mapp who finds meeting
locations, negotiates contracts, work with vendors in the
exhibit hall, and handles all of the other tasks that must be
completed to make our meeting a success. I continue to
encourage you, our members, to extend your gratitude to
these hard working volunteers when you see them at the
meeting.
This year’s meeting has a very full schedule and it is
full of opportunities to learn more about new technology
and expand your horizons. We will begin the week with
our Opening Ceremony speaker, Donna Boston, who will
address new technology fielding for bioagent detection. Then we will move to the workshops, short topics, poster session,
and the General Session to learn more about what is new and innovative in laboratory science with a focus on new emerging
technology that may be on our horizon. There is certainly something for everyone at the meeting and it continues to be a
great opportunity to meet other laboratory scientists from other services and agencies.
Of course, we will have some fun too and the President’s Reception will host a Caddy Shack theme with everyone being
encouraged to wear favorite golfing attire. I plan to wear my favorite gear and we will give a prize or two away to those
with the “best” or “worst” outfit. Come prepared to have fun; I look forward to seeing everyone during the evening.
This meeting is shaping up to be another world-class event and if you need more information please visit the SAFMLS
website (http://www.safmls.org) to find out more about the events scheduled this year. The website continues to expand and
it gets better with every passing year thanks to the hard work of our webmaster. The website has more information about
the annual meeting and the society so please visit and find out what is happening.
The Planning Committee will continue to work all the way to the meeting kick-off on 10 February 2008. The VicePresident and Chair of the Planning Committee, CDR Larry Ciolorito, would love to hear from you if you would like to help
out. He can be reached through the SAFMLS Board of Director’s webpage. Please feel free to let us know how we can
improve the meetings in the future.
In closing, I would like to thank the membership for their confidence in me. It has been an honor to lead this Society of
dedicated, selfless professionals. I look forward to seeing you in New Orleans. Travel safe.
Visit Our WEBSITE
at
www.safmls.org
4
Society Scope
Consultant’s Corner
Larry Ciolorito, CDR MSC USN
“Those who do not know their own history are condemned to repeat it”- George Santayana
“History is more or less bunk….the only history that is worth a tinker’s dam is the history we made today.”
- Henry Ford
Given that this submission is an historical review, you can guess which of the above quotes I favor. History doesn’t
actually repeat itself, but a review of the patterns (and “lessons”) of history can inform public policy- if we can agree on
what those patterns and lessons are.
We live today in an age of challenges to which military medicine has responded brilliantly- global engagement, the
“Global War on Terrorism”, asymmetric warfare in Iraq and Afghanistan, “nation building” efforts, and heightened demand
for humanitarian interventions, among other factors. More broadly, today’s strategic environment is characterized by relative
U.S. dominance in world affairs, with an international system that, if not truly “unipolar”, at least features the United States
as primus inter pares - first among equals. The evolution of that strategic environment holds broad implications for not just
the United States in general, but for the Department of Defense and military medicine in particular.
Most Americans believe that our present degree of global engagement and involvement in active conflicts is an historical
anomaly, but history indicates otherwise. While it is true that America’s early military strategy emphasized coastal defense
and a small standing army, this reflected more a limitation in the nation’s means at that time than its ends. Indeed, it is
remarkable how often our early republic, commonly characterized as “isolationist”, was engaged in operations beyond
her own borders. From the invasion of Canada during the Revolutionary War through the three year long Philippine War
beginning in 1899, America engaged in frequent interventions, adventures and outright conquests during the supposedly
“isolationist” 19th century. These included Jefferson’s campaign against the Barbary states of North Africa, the MexicanAmerican War, the forced opening of Japan by Commodore Perry, and the Spanish-American War. An amazing number
of armed interventions dot the rest of that century, many taking place in the Pacific, Latin America, and the still unsettled
American West.
Having consolidated power in the Americas, in the 20th century the United States focused on projecting power abroad
in a more sustained way. Some date America’s emergence as a true world power to 100 years ago (Dec 1907), when
President Teddy Roosevelt dispatched a fleet of warships, the “Great White Fleet”, to circumnavigate the globe. While
America occasionally clashed with Britain during the 19th century, in truth we mostly sheltered under the “Pax Brittanica”,
developing economically and consolidating our own power while Britain shouldered the burden of maintaining the world
order. However, with the steady decline in Britain’s relative economic and military strength after 1900, America would
increasingly shoulder the burdens of the international system. This was a truth accepted only reluctantly, particularly
during the interwar period (1919 to 1939), again commonly characterized as “isolationist”. Still, even America’s relative
“isolationism” between the World Wars reflected the desire to avoid involvement in another destructive European war
rather than a true disengagement from world affairs; elsewhere, military intervention continued with multiple long-term
occupations throughout Latin America, including the Dominican Republic, Haiti and Cuba. American naval and land
forces were also engaged in China in varying capacities for decades, and even spent four years (1918-1922) in Russia in the
aftermath of the Bolshevik Revolution! How many of you remember (or ever knew) that America “invaded” Russia during
the 20th century?
Even before the bombing of the Pacific Fleet at Pearl Harbor in 1941, America was sliding towards open opposition
to the Axis Powers, driven by our national interest in preventing any single foreign power from dominating the Eurasian
land mass. This same interest, as well as the perceived threat of expansionist global Communism, drove us towards fullscale global engagement in the post-war/Cold War era. While the Cold War flared into hot conflict from time to time (most
notably in Korea and Vietnam) and our military presence became truly global, in many ways military interventions were
constrained during this era, as the risk of miscalculation, escalation, and nuclear conflict loomed like a specter over all
Con’t on page 6 - Consultant’s Corner
5
Society Scope
Con’t from page 5 - Consultant’s Corner
military operations. But even in this era interventions persisted - the Marines moved into Lebanon in 1958 and 1983; we
instituted a military blockade of Cuba during the “Cuban Missile Crisis” of 1962; we attempted to rescue the American
hostages from Iran in 1980; we invaded Grenada in 1983, and we had multiple clashes with Libya in the mid-1980s, among
other incidents.
Finally, the “post-Cold War” period has in my view been characterized by two major trends. One is the resumption of
seemingly ad-hoc interventions driven by some combination of national interests, national ideals, and domestic politics.
These include interventions in Panama, Somalia, the former Yugoslavia, and Haiti. The second major trend is our continuing,
major military engagement throughout the Middle East, driven by the over-riding necessity of securing the world’s energy
supplies and, increasingly, the threat of international (Islamic) terrorism made manifest most starkly during the 9/11 attacks.
It is this second major post-Cold War trend that largely occupies us at present, as many of the presentations at our upcoming
annual meeting will attest.
With history as our guide, we must know that true peace and stability are ephemeral. New challenges will rise to
challenge a still indispensable America, and we and our successors will need to find the answers to strategic questions,
answers which will have major implications for our military posture. For example, can the metaphorical sailing of China’s
own “Great White Fleet” be far away, and will the rise of China to world power status portend dislocations to the international
system such as those engendered by the rise of Germany, Japan, and the Soviet Union? Can we peacefully manage the
potential “clash of civilizations” between the Muslim and Western worlds? Can we continue to secure the world’s energy
supplies while successfully diversifying energy sources and moving away from a reliance on fossil fuels? Can we prevent
“asymmetric warfare” and terrorism from evolving into ever more destructive forms, including the specter of nuclear
terrorism? Can we prevent terrorists or anti-American states from using energy supplies as a weapon?
This review is meant to reflect “is” rather than “ought”- the way things are rather than the way they necessarily should
be. Nonetheless, a proper understanding of America’s global responsibilities, her continuing status as the “indispensable
nation”, and her tendency from the very beginning to utilize all levers of power to secure the national interest, demonstrates
that military medicine must plan for continued engagement and action rather than a return to some peaceful time that never
was. The challenges we face today are not an aberration but rather a return to normalcy, and in the light of this sobering
reality we can rejoice in the knowledge that military medicine and our laboratory community were never better prepared for
the coming challenges. In one sense, then, Henry Ford was correct - what counts is neither history itself, nor the lessons of
history per se, but rather how we shape the future by translating those lessons into action in the here and now.
Con’t from page 1 - Transfer of Authority
carefully planned and well coordinated transition. It necessitates intense hands-on supervision from both the outgoing and
incoming laboratory leadership. Every important skill set must be passed on during the short transition period; if one critical
skill, procedure, or policy is overlooked the outcome could be disastrous.
The outgoing leadership should have the responsibility for planning the transition. They have recent hands-on experience
and intimate knowledge of the intricacies of the deployed laboratory. Critical tasks required at each skill level must be
identified. Leaders must recognize the technicians on their staff that are technically proficient at critical skills and are
capable of training the new staff. Outgoing personnel should develop a detailed, systematic training plan that emphasizes
basic skills but quickly builds upon previous experience so that the entire laboratory process is assimilated quickly. A
thorough checklist used as a training aid is invaluable, as it allows both the trainer and the trainee to immediately assess
how well personnel are progressing. The checklist also facilitates the leadership’s oversight of the transition and serves
as a record of initial competency assessment. This process should be performed at all levels, from bench techs to OIC.
Importantly, incoming leaders must learn everything from critical bench skills, to work flow, logistical processes, and
administrative policies.
Ideally, inbound leaders should be able to assess the technical staff prior to deployment to establish strengths and
weaknesses. Frequently, staff filling CSH positions are PROFIS (professional filler system, the Army personnel system
used to fill deployable medical units) and unfamiliar with the organic staff. Unfortunately, the few opportunities to establish
a rapport and determine the skill base may only occur during training rotations such as at JRTC (Joint Readiness Training
Center) and the integration period of PROFIS prior to deployment. As such, the lab officer must frequently rely on the most
senior NCO to be a strong partner to establish strengths and roles prior to deployment. Once identified, the leaders should
assign technicians based on their strong backgrounds in key areas and select the subject matter experts whose training is
Con’t on page 7 - Transfer of Authority
6
Con’t from page 6 - Transfer of Authority
Society Scope
tailored to specific areas. For example, a technician with blood donor experience might be a strong choice as an apheresis
technician; an individual with previous microbiology experience is a logical choice for that work area. Additionally, certain
instruments can be more complicated than others. Selecting someone with the appropriate skill sets to work on the VITROS
or Mini Vidas is a wise choice. During the transition phase it is important to have the subject matter experts concentrate their
training in their skill set. They can later serve as trainers for the remainder of the incoming personnel.
Although ensuring basic personnel competency on all instrumentation and test kits is critical, another key concept that
must be passed on are the “systems” used by the lab. Much of the testing performed in support of combat trauma is STAT
testing. Release of results as quickly as possible is often critical in the performance of life-saving medical interventions.
Ensuring that incoming personnel learn workflow systems is as important as ensuring they are competent in performing the
test procedures. Turn-around times associated with the instruments in use – along with acceptance of specimens, triaging
tests, recording results, and releasing results – are imperative. The transition training plan must take this into account.
Personnel that are selected to work in a STAT lab capacity should have demonstrated organizational skills.
In a perfect world, the workload during the transition period would start off light and progress to very intense and hectic.
Unfortunately, given the nature of war and the resulting trauma cases, the workload can rarely be predicted and fluctuations
result in unpredictable patterns. For this reason, the training program must be flexible. It must give the incoming personnel
the opportunity to gain basic competencies as well as learn workflow. However, test turn-around time or result quality can
not be sacrificed for the sake of training. This is an environment where inaccurate or delayed test results can result in a
devastating outcome. It is critical that the trainers be able to gauge the progress of trainees, give them the maximum amount
of work from which to learn, but be able to recognize the appropriate time to intervene. This requires close coordination
and observation on the part of both outgoing and incoming laboratory leadership.
One positive aspect of the military system that can allow for a smooth transition period between combat support
hospitals is sending key personnel as part of the advance party. Historically, advance parties only involved the command
and administrative staff, but inclusion of key section chiefs, such as the laboratory OIC, helps ensure a successful transition
of authority. The additional time on the ground allows the incoming laboratory leadership to shadow the outgoing leadership
and to assess key tasks, processes, systems, and review workflow. This overlap can improve the ability of the incoming
leadership to develop an understanding of the critical tasks that must be passed on during the transition. It also allows
incoming staff the time to become familiar with other personnel in the hospital that have different rotation cycles. Many of
the health care providers (HCP) are 180-day rotators and may overlap into the new command. The opportunity to meet and
establish positive relationships can be essential to meeting the HCP and patient needs during high patient census times.
Though successfully replacing an entire laboratory staff seemingly overnight can be a daunting task, the difficulties can
be mitigated. Prior planning, strong leadership, personnel assessment, and technical competence all play a role in paving
the way for a successful transition. For leadership, this is a great opportunity; for laboratorians, it is an opportunity unique
to the deployed environment, and one that should be sought and accepted.
7
Society Scope
CALL FOR NOMINATIONS FOR
2008 SAFMLS BOARD POSITIONS
• Open Positions: President-Elect (Navy Nominee), Vice President (Army Nominee), Secretary, Army/Navy/Air
Force Members-at-Large
• Nominee must be a regular member of SAFMLS, not anticipating retirement within the
next year, and must be willing and able to attend board meetings.
• Send the following NLT 1 Feb 08 to the SAFMLS Secretary, CDR Christine Howe: [email protected]. Phone: 757-953-1698/DSN: 377-1698
•
•
•
•
•
•
o Nomination Letter
o Letter of Intent (1 page)
o Picture (electronic preferred)
o CV (1 page)
The Officers of the Society shall be, by order of succession, President, Vice‑President, Treasurer, and Secretary. A
conscious effort should be made to effect multiple agency representation among the Officers of the Society and under no circumstances will the President be from the same service for more than two consecutive terms.
The Officers and a President‑Elect shall be elected annually from among the commissioned officers of the Society
by majority vote during the Business Session at each Annual Meeting, with the exception of the Treasurer and Secretary, who shall be elected for a three-year term.
The Officers shall take office at the conclusion of each Annual Meeting, and shall be responsible for the affairs of the
Society during the following year, and for the conduct of the succeeding Annual Meeting.
The President‑Elect will serve as a Society President the year following the term of office of the current President,
and shall serve during this interim period as a non‑voting member in all meetings of the Board of Directors, unless
the President‑Elect qualifies as a voting member under Articles IV or V or the Bylaws.
The Vice President, in the event the President is unable to serve, shall assume all of the President’s functions.
There shall be seven Members-at-Large, each elected for a period of two years. Six of the seven Members-at-Large
shall be Commissioned Officer Members, with not more than two members from any one service. In addition, one
term for each service will expire each year. The seventh Member-at-Large will be an Enlisted Member representing
any service. Each Member-at-Large will have one vote.
DEADLINE: 1 FEB 2008
8
Society Scope
SAFMLS 2008
Annual Meeting and Exposition
New Orleans, Louisiana
10 February to 14 February 2008
Hilton New Orleans Riverside
F
or our first time in New Orleans, the Hilton New Orleans
Riverside promises to be a great location for our world-class
annual meeting. In the “center of it all,” the newly renovated
Hilton New Orleans Riverside hotel is a full service luxury
complex that is actually a “city within itself,” located on the
banks of the Mississippi River with easy access to everything
New Orleans has to offer. Dining, shopping, and entertainment
are just steps away. The Riverwalk Marketplace (with over 140
shops and food outlets) is at the hotel’s doorstep, as are Harrah’s
Casino, the Aquarium of the Americas, the IMAX Theater,
the French Quarter, the Ernest N. Morial Convention Center,
the National D-Day Museum, the Ogden Museum, the Arts
District, the Louisiana Children’s Museum, and the Riverfront
Streetcar. Transportation from the Louis Armstrong International
Airport is an easy 25-minute shuttle or taxi ride.
Make hotel reservations now by calling 1-800-445-8667. Be
sure to request the Hilton New Orleans Riverside and identify
yourself as a member of the SAFMLS 2008 Annual Meeting.
9
Society Scope
SAFMLS
President’s Reception
I would like this year to be a fun year for all during the reception so no ties
or jackets or any of that other constricting clothing we hate so much.
Please everyone feel free to wear your favorite golfing attire and RELAX!
I plan to wear my favorite stuff but I don’t want to
give up too much about my clothing so here are a
few snapshots to help you decide what to wear.
The choice is yours. Please come dressed for
fun and I look forward to seeing you there.
Kevin
From this
To this
Join Us for a Good Time!
10
Society Scope
Come join us for this year’s
SAFMLS
Fun Run/
Walk
WHO:
All Runners/Walkers looking to have FUN!!
WHAT: An orienteering type event where participants have
one hour to find as many points as possible around
town.
WHEN: Wednesday, 13 February 2008 Registration 0530
Start promptly at 0600… YES, in the morning!
WHERE: Meet at Hilton New Orleans Riverside Hotel Lobby
WHY: To exercise, enjoy the city, and have FUN before a
long day in meetings
EXTRAS: Complementary T-Shirt and 1st, 2nd, 3rd place
prizes for each event (Prizes given at Awards
breakfast)
SPONSOR: CHIRON / Novartis Vaccines and Diagnostics
REGISTRATION: Just Show Up!!
11
Society Scope
12
Society Scope
CONTINUING EDUCATION UNITS (CEU Credit Hours)
Richard Schoske, Lt Col, USAF, BSC, Ph.D.
Chief, Chemical, Biological, Defense Surveillance
Air Force Medical Operations Agency
Bolling AFB, DC
P.A.C.E.® Coordinator for 2008 SAFMLS Annual Meeting
The SAFMLS organization provides continuing education units (CEUs) to all annual meetings through the
American Society for Clinical Laboratory Scientists (ASCLS). The major laboratory credentialing agencies,
ASCP and NCA, both require 36 CEUs every three years. Your annual SAFMLS meeting provides the ability for
you to earn CEUs through Professional Acknowledgement for Continuing Education (P.A.C.E.®), and certified by
ASCLS. P.A.C.E.® Continuing Education Contact Hours also satisfy the continuing education requirements for
federal and state licensure, local employers, and regulatory agency recertification.
It is the responsibility of each attendee to ensure he/she SIGNS IN on the attendance form prior to the start
of the briefing for EACH workshop and short topic, as well as the Opening Ceremony Lecture. If you do not
legibly sign the attendance roster prior to the start of the lecture you cannot obtain CEU credit hours. CEU
credit hours must be verifiable by ASCLS through signatures on attendance logs. Additionally, your registration
packet contains certificate of attendance forms that are to be used to document your attendance at the short topics,
workshops and opening ceremonies. Please be sure to accurately fill out these certificates of attendance. Finally,
you will also rate whether the learning objectives were met via your feedback following the briefing. Please take
the time to fill out each respective feedback forms. Your presenters use the information provided to improve their
briefings for future audiences.
SAFMLS attendees are laboratory professionals who continue to share and enhance their knowledge, partly
through attendance at the meeting. Please take the time to thank all of those who voluntarily prepare and present
workshops, short topics and posters at our annual meeting. Without their efforts we would not have a meeting to
attend. Thanks and have a wonderful time in New Orleans!
Opening Ceremonies
JBAIDS: Integrating Technology with Biodefense
Ms. Donna S. Boston, JBAIDS Program Manager
Monday, 11 Feb 08 at 0800
Hilton Riverside’s Jefferson Ballroom
13
Society Scope
2008 SAFMLS WORKSHOPS AND ROOM ASSIGNMENTS
11 Feb 08 (Monday)
1300-1500 2-Hour Workshops
#1 Acing Laboratory Certifications:
From Entry Level to Advanced.....
Presenter(s): Nathan H. Johnson, Lt Col, USAF
Jonathan R. Shane, SMSgt, USAF
Jason J. Jacobsen, SSgt, USAF
Melrose
Abstract: This workshop is designed for individuals of all ranks who are interested in laboratory certifications, from
initial to advanced certifications. The presenters will share practical advice on how they turned their military laboratory
experience into valuable credentials. Topics to be covered include the importance and value of certifications, the types of
certifications available, the experience and education required to become eligible to take certification exams, and practical
tips and resources for passing the exams. Ample time will be allocated for a question and answer period at the conclusion
of the presentation.
Objectives:
1. Identify organizations that laboratorians may obtain certification from.
2. Compare various styles for preparation of certification exams.
3. Associate educational and experience levels with eligibility for certification exams.
#2 COMMUNICATION TECHNIQUES AND STRATEGIES FOR THE
LABORATORY OFFICER.....
Presenter(s): Ms. Julie L. Oliveri
Rosedown
Abstract: This communications workshop will demonstrate how basic communications strategies can be used to
keep your chain-of-command informed of your successes; build effective relationships with the military media; work
effectively with your Public Affairs Officer, and; turn potential negative publicity into positive publicity. Designed as
an interactive exercise to teach and subsequently demonstrate basic communications techniques, workshop participants
will learn how to formulate and communicate a strong positive message to the appropriate audience. For the laboratory
officer, audiences can include the hospital command structure, installation command structure, military media and civilian
press. This workshop will teach simple ways to tailor your message to a particular audience as well as effective ways to
work with your public affairs office. Participants will leave with an understanding of basic communications techniques,
and how to adapt and best use these techniques as needed.
Objectives:
1. Learn basic communication strategies for informing command and maintaining media relationships.
2. Demonstrate understanding of creating positive media messaging.
3. Describe ways to effectively work with public affairs offices.
#3 Army AMEDD Officer Career Development.....
Presenter(s): Marilyn Brew, COL, USA
Magnolia
Abstract: Officer Development and Career Management is provided for Army AMEDD Officers in accordance with DA
Pamphlet 600-4, dated June 2007. It provides guidance to commanders, career managers, mentors and individual officers
concerning leader development to include the duties, responsibilities, and roles of commissioned and warrant officers of
14
Society Scope
the Army Medical Department (AMEDD) in support of the U.S. Army and the Department of Defense (DOD). DA PAM
600-4 should also be used as a general guide to plan assignments, education, and training for optimum military service by
each AMEDD officer.
A panel of senior Army Lab Officers will provide a general overview and specific guidance of what Officer Development
and Career Management consist of and provide tools for development and career management.
Objectives:
1. Identify and discuss framework for Officer Development and Career Management.
2. Using a panel, provide guidance and tools to plan your development.
3. Discuss tools to assist in managing your development and career.
1300-1730 4-Hour Workshops
#4 Naval Officers-Preparing Your Record For Selection/
Promotion Boards.....
Presenter(s): Christine Howe, CDR, USN
Cynthia Wilkerson, CDR, USN
Norwich
Abstract: This workshop is targeted for Navy laboratory officers and is intended to provide information on how to
prepare officer records to be reviewed by Navy selection/promotion boards. The information will be presented by two
senior Navy Laboratory Officers who have served as recorders or board members on selection and promotion boards.
This workshop will cover various types of Officer records; explain the meaning/purpose of different information found on
those records and how to get the information entered into your record. It will also describe the promotion/selection board
process at Bureau of Naval Personnel, Millington, TN and offer insight into the process used to select officers for either
promotion or educational programs. Information will also be presented on how to prepare your record if you have “Failed
to Select or FOS” for the next rank.
Objectives:
1. Educate attendees on how to prepare their officer record to be reviewed by Navy selection/promotion.
2. Review Officer Summary Record/Performance Summary Record, explain entries.
3. Describe promotion/selection board process at Bureau of Naval Personnel, Millington, TN.
#5 Case Studies in Clinical Microbiology.....
Presenter(s): Gerald T. Van Horn, CPT, USA
Mark R Scheckelhoff, CPT, USA
Wade Aldous, LTC,USA
Helen Viscount, LTC, USA
Edward Ager, MAJ, USA
Gerald Van Horn, CPT, USA
Stuart Tyner, CPT, USA
Mark Scheckelhoff, CPT, USA
Ms. Yadira Encina
Jasperwood
Abstract: Ten clinically relevant case studies in microbiology will be presented during this session. The target audience
includes anyone interested in the laboratory diagnosis of infectious disease. Representatives from multiple Army Medical
Centers will provide case study information in an interactive format that will allow the audience members to test their
knowledge of clinical microbiology as well as provide insight to alternative diagnostic methods. Topical areas will
include culture, microscopy, biochemical profile and clinical correlation.
15
Society Scope
Objectives:
1. Identify potential pathogens by applying an understanding of current issues and identification techniques to clinical
case presentations.
2. Describe routine identification algorithms used in laboratory diagnosis of infection.
3. Discuss current controversies in the laboratory diagnosis of infection.
#6 Dynamic Review of Clinical Chemistry Part 1.....
Presenter(s): David A. Smith, LTC, USA
Frank Wians, LTC(ret), USAF
Jude Abadie, MAJ, USA
Oak Alley
Abstract: This workshop will focus on related topics in clinical chemistry. The format will involve dynamic lectures that
include case studies in conjunction with discussions among the three expert panel presenters. We will encourage audience
participation during the jeopardy (Army vs. Air Force vs. Navy) style competition that will be conducted during the last
portion of the workshop. This workshop will focus on diabetes to include the latest in screening, diagnosis, guidelines,
and complications. The discussion will then focus on pregnancy to include fetal maternal screening, gestational diabetes,
and other related complications of pregnancy. The discussions will start with background pathophysiology fundamentals
followed by general background information. After these fundamentals are discussed, specific cases will be presented and
solved from the point of view of the patient, clinician, and laboratory. The review session will take the part of a jeopardy
competition show, where teams will be created, rules will be established, the panel will present questions, team potions
will be scored, and a prize(s) will be awarded.
Objectives:
1. Describe underlying pathophysiology of disorders related to diabetic states.
2. Outline laboratory and testing used for screening, monitoring, and diagnosing disorders associated with insulin
resistance and insufficiency.
3. Summarize current laboratory guidelines used in the medical management of diseases associated with diabetes.
#7 Forward Thinking in Blood Bank.....
Presenter(s): George A. Hestilow Capt, USAF
Paul R. Eden, Jr., Capt, USAF
Aaron W. Lambert, Capt USAF
Craig W. Mester, CPT, USA
Karen Joy Buikema, Capt, USAF
Elmwood
Abstract: This workshop is designed to demonstrate various approaches in the management and performance of critical
processes within the Blood Bank. Participants will be introduced to topics such as ABO discrepancies, equipment/process
validations, urgent blood request response, massive transfusion protocols and the management of solid organ tissues. This
workshop will target participants from entry level to advanced levels of blood banking and provide a solid framework for
officers interested in attending the Armed Services Blood Bank Fellowship.
Objectives:
1. Demonstrate problem solving skills to resolve complex ABO discrepancies cases.
2. Plan, develop, evaluate and implement validation protocols for new equipment or processes in Blood Bank.
3. Expedite Urgent Request and Massive Transfusion protocols within accreditation standards.
#8 What every usaf laboratorian should know.....
Presenter(s): Imelda M. Catalasan, Maj, USAF
Elizabeth A. Macias, Ph D
Ketan Patel, Ph D
16
Belle Chasse
Society Scope
Abstract: This workshop is mandatory for all junior USAF lab officers (in the ranks of O-3 and below) and USAF
enlisted members (E-5 thru E-7). All others are welcome to attend. This course is designed to provide information on
clinical laboratory and personnel management. Topics of discussion will include a review of the requirements of the
Clinical Laboratory Improvement Program, laboratory and facility accreditation procedures, evaluation of proficiency
testing, quality control assessment, workload reporting, manpower model, laboratory response network (LRN)
requirements, avian influenza update, leadership in a laboratory setting, deployment training requirements and more.
Objectives:
1. Provide a review of the Armed Forces Institute of Pathology Pamphlet 40-24 and detailed information on accreditation
procedures and inspections.
2. Understand the importance of workload reporting and how it affects lab staffing at individual facilities.
3. Identify the roles/responsibilities of USAF laboratories in biodefense and discuss compliance with proficiency testing
requirements.
1530-1730 2-Hour Workshops
#9 AVOIDING PHLEBOTOMY-RELATED INJURIES AND LITIGATION.....
Presenter(s): Mr. Dennis J. Ernst
Melrose
Abstract: This program identifies common errors in the performance of venipunctures that cause minor and catastrophic
injuries to patients and bring legal action against phlebotomists, laboratories and hospitals. It outlines policies, procedures
and practices that phlebotomists and their managers can implement to minimize their risk of litigation.
Objectives:
1. Identify the most common injuries poor phlebotomy technique inflicts upon patients.
2. Associate errors in technique, judgment, and supervision with phlebotomy-related injuries.
3. Evaluate their own vulnerability or the vulnerability of their employees and facility to phlebotomy-related lawsuits.
#10 Quality Management Tools.....
Presenter(s): Marilyn Brew, COL , USA
Robin M. Wein, LTC, USAR
Mr. Jose Olivencia
Ms. Gerry H. Yang
Rosedown
Abstract: Establishing and integrating quality into all processes and procedures in the laboratory will ultimately yield
quality laboratory support and services that either meet or exceed customer expectations and laboratory accreditation and
regulatory requirements.
This workshop will review the intent and components of a quality program as defined by several Clinical and Laboratory
Standards Institute guidelines. Additionally, the presenters will share their respective tools they have developed and
implemented in their respective organizations to establish, sustain, and improve quality which ultimately leaves the lab
accreditation ready all the time.
Objectives:
1. Discuss staff roles and responsibilities in the quality program within the context of CLSI standards HS1, GP2, GP22,
and GP26.
2. Review process mapping.
3. Share basic tools in use to meet the intent of a quality program (audit checklists, document control, occurrence mgmt,
integration into PI program and minutes).
17
Society Scope
#11 The New and Improved Surveillance Directorate.....
Presenter(s): Kathy Taylor, Maj, USAF
Magnolia
Abstract: This workshop is an expanded look into the Surveillance Directorate’s current capabilities and career
broadening opportunities for 43T’s and 4T0X1’s. Participants will gain valuable first-hand knowledge of the
transformation of the Epidemiological Reference laboratory which houses the most extensive reference testing in the
Air Force and performs over 995 thousand tests per year. We will showcase our transformation/face lift into current
technology and improvement efficiencies that led to 24-hour result turn-around times. We will educate personnel on
collection techniques for influenza testing as well as proper shipment techniques to ensure sample stability through the
shipment process. The third and final portion of the workshop will be devoted to customer service initiatives and other
improvement programs developed in the past year to enhance customer relationships. The Epidemiological Surveillance
laboratory management team and its laboratorians share a unified and common goal of providing quality and timely
results to our customers. Each attendee will have an opportunity to engage with us, the service-provider, in an open forum
to discuss relevant, informative, and meaningful issues and address matters of concern in Q&A.
Objectives:
1. Inform the 43T and 4T0X1 about surveillance directorate career broadening opportunities.
2. Provide valuable first-hand knowledge of the Epi Lab Transformation.
3. Provide additional information for customer service and support.
#12 Transforming From Military Laboratorian to
Civilian Leader.....
Presenter(s): Nathan Johnson, Lt Col, USAF
Marlborough A
Abstract: This workshop is intended for military personnel who expect to separate from the military in the next two
years or who plan to retire within the next ten years or those that supervise such individuals. There is little doubt among
those in the military laboratory community with respect to the value of our personnel. However, we may be doing
too little to prepare our outstanding staff for life after the military. Although the different services have outstanding
programs to prepare for life after the military in general terms, it is usually left to the individual to obtain knowledge
concerning the specific facets of after-military employment. We will discuss and review strategies to enhance the chances
of our personnel to obtain great jobs in their after-military life. The cornerstones of this workshop will be a review of
practical methods of meeting educational/certification requirements for civilian employment, methods of semantically
translating military experience and training into a resume that is attractive to civilian employers, non traditional roles for
laboratorians, and available employment resources. Time will be allocated for interactive discussion for the dissemination
of information that may be useful to all in attendance.
Objectives:
1. Review non -traditional roles for laboratorians.
2. Categorize pathways to obtain required education required for civilian employment.
3. Explain techniques for using military experience to obtain a great civilian job.
12 Feb 08 (Tuesday)
0730-0930 2-Hour Workshops
#13 Army Microbiologist Round Table Discussion.....
Presenter(s): Jeanne Geyer, MAJ, USA
Melrose
Abstract: Round table discussion geared for the company and field grade Army Microbiologist. This 2 hour workshop
will provide an opportunity for Army Microbiologists to discuss topics of importance that need to be addressed during the
upcoming year. This workshop will be restricted to Active Duty Army and USAR 71A attendance only.
18
Society Scope
Objectives:
1. Provide a mentorship opportunity for Army Microbiologists.
2. Provide an open forum to discuss issues relevant to professional development.
3. Identify key issues that need to be addressed by leadership.
#14 DOD CLINICAL LABORATORY IMPROVEMENT PROGRAM (CLIP)......
Presenter(s): Gerry S. Rapisura, HMC, USN
Gary S. Brown, MSgt, USAF
Jasperwood
Abstract: This presentation will give an overview of all of the components of the DoD Clinical Laboratory Improvement
program. The main topics will be review of Armed Forces Institute of Pathology Pamphlet 40-24, CLIP registration,
CAP survey orders, accreditation inspections and resolution of PT failures. We will briefly discuss the testing personnel
and director qualifications for the different levels of CLIP certificates. Give insight into how the proficiency testing and
accreditation inspections are managed within the different services. Offer a talk-through of steps involved in resolving
repetitive PT failures.
Objectives:
1. Overview of DoD CLIP registration and certificates.
2. CAP Laboratory Accreditation Program and Proficiency Testing contract.
3. Resolution of PT failures.
#15 AFMS Laboratory Biological Defense Policy/Guidance Update.....
Oak Alley
Presenter(s): Patricia A. Reilly, Col, USAF
Richard Schoske, Lt Col, USAF
Sean M. Chickery, Capt, USAF
Elizabeth A. Macias, Ph D
Abstract: The Air Force Laboratory Biological Defense Steering Committee (AFlab-BDSC) serves as the advisory body
to AF/SG3 on all laboratory biological defense issues. The AFlab-BDSC develops and facilitates Expeditionary, Fixed
Site Homeland Defense and Homeland Security policies, plans, projects, and procedures at the request of the SG3. In this
workshop you will be provided with the latest AF lab biodefense laboratory policy and guidance to include information on
the Homestation Laboratory Response Team and the Laboratory Response Network. Furthermore, you will be provided
with the latest information concerning the Joint Biological Agent Identification and Diagnostic System and the Bioveris
M1M instrument. This update will include the latest information on training, instrument sustainment, and what is the
vision for the future regarding identification of biological threat agents. Finally, the workshop participant should ensure
the information provided is incorporated in their installation specific medical contingency response plans under annex N
(C-CBRN Response) as appropriate.
Objectives:
1. Explain current AFMS Biodefense laboratory policy to installation leadership including first responders (i.e., security
forces, civil engineering readiness, mission support group).
2. Incorporate latest AFMS Biodefense laboratory policy and guidance into installation specific medical contingency
response plans.
3. Differentiate between AFMS Homestation Medical Laboratory Response capability and Laboratory Response
Network role.
#16 Bugs, Drugs, and Thugs: Case Studies From The Nefarious, Kooky and Mysterious Side .....
Elmwood
Presenter(s): Nathan Johnson, Lt Col, USAF
Michael Forgione, Lt Col, USAF
David Watson, Maj, USAF
19
Society Scope
Abstract: This workshop is intended for individuals interested in taking a fast paced trip thru the world of unusual
medical cases. The presenters (an infectious disease physician, a toxicologist, and a medical microbiologist) will guide
you thru several intriguing cases that will leave you scratching your head and asking, “Did I just hear that”? The case
studies will be similar to amalgam of Marcus Welbly, CSI, The Twilight Zone, and the Discovery Channel! This is one
workshop that you will not want to miss!
Objectives:
1. Appreciate the need to think “outside the box” when dealing with medical issues.
2. Interpret clinical data associated with unusual cases.
3. Understand mechanism of action of various toxins, microbes, and novel therapeutics.
0730-1200 4-Hour Workshops
#17 Armed Services Blood Program Update.....
Presenter(s): Michael C. Libby, CDR, USN
Belle Chasse
Abstract: The Armed Services Blood Program Office (ASBPO) was established by the Assistant Secretary of Defense
for Health Affairs to coordinate the blood programs of the Military Services and the Unified Commands. The ASBP
is currently undergoing transformation in business practices through development of novel marketing strategies;
redesign of the DBSS requirements and procurement processes; and support to innovations in information management
research/development through partnerships with other federal and civilian agencies. This workshop updates participants
on the following ASBP activities: (1) Operations in support of the Global War on Terrorism (2) Business practice
transformations (3) Defense Blood Standard System enhancements (4) Global strategic alliances and (5) Research and
Development initiatives. Additionally, each service blood program will provide updates on the unique challenges of their
specific program operations.
Objectives:
1. Update attendees on the business transformation and future design of the ASBP and the service blood programs.
2. Provide information on the ASBP role in disaster response/preparedness and coordination efforts with the Department
of Health and Human Services. Detail current status of the Frozen Blood Program, iceless blood shipping solutions, and
Information Technology initiatives.
3. Update attendees on the status of the Defense Blood Standard System (DBSS) and current blood research and
development projects.
#18 Basic CHCS Skills .....
Presenter(s): Donna J. Fox, Capt, USAF
Karen Chisholm, 1Lt, USAF
Fountain Room
Abstract: The Composite HealthCare System (CHCS) is the Laboratory Information System (LIS) for DoD. This
workshop is geared toward individuals new to CHCS, those individuals running over their own labs and anyone who
has not worked with CHCS in a few years. We will focus on basic adhocing, building and updating test files, and
updating the laboratory work element file. We will also cover options for supervisor’s review of results through specimen
master logs or reviewing by exception and the documentation of these reviews. CHCS tips and time savers will also be
discussed.
Objectives:
1. Participants will have a basic understanding of CHCS adhocing.
2. Participants will gain the knowledge to update their platform’s Laboratory Work Element.
3. Participants will be able to build tests in CHCS using file and table fields.
20
Society Scope
#19 Dynamic Review of Clinical Chemistry Pt 2.....
Presenter(s): David A. Smith, LTC, USA
Frank Wians, LTC(ret), USAF
Jude Abadie, MAJ, USA
Rosedown
Abstract: This workshop will focus on using the clinical laboratory to explore related topics in clinical chemistry. The
format will involve dynamic lectures that include case studies in conjunction with discussions among the three expert
panel presenters. We will encourage audience participation during the jeopardy style (Army vs. Air Force vs. Navy)
competition that will be conducted during the last portion of the workshop. This workshop will focus on laboratory use
with respect to test ordering, cardiac ischemic and injury markers, alcohol abuse markers, inflammatory disease markers,
and HAMA interferences in immunology testing. These topics will address areas of screening, diagnosis, guidelines,
and complications. Each discussions will start with background pathophysiology fundamentals followed by general
information. After these fundamentals are established, specific cases will be presented and solved from the point of view
of the patient, clinician, and laboratory. The review session will take the part of a jeopardy competition show (Army vs.
Air Force, vs. Navy), where teams will be created, rules will be established, the panel will present questions, team potions
will be scored, and a prize(s) will be awarded.
Objectives:
1. Describe principles of laboratory use and test ordering.
2. Outline laboratory guidelines used to assess markers of ischemia, injury, inflammation, and alcohol consumption.
3. Summarize the effects of HAMA interfering substances on common laboratory tests.
#20 LABORATORY DEVELOPMENTS WITHIN LRMC AND THE EUROPE REGIONAL MEDICAL COMMAND
IN SUPPORT OF THE GLOBAL WAR ON TERRORISM.....
Magnolia
Presenter(s): Marc H. Labovich, LTC, USA
Aziz N. Qabar, LTC, USA
Jose Quesada, MAJ, USA
David Sartori, MAJ, USA
Lloyd Roesch, CPT, USA
Joseph Letourneau, 1LT, USA
Sabrina Perez, SFC, USA
Gabrielle Duffey, HMC, USN
Mark Morrone, Capt, USAF
Philip Bossart, Capt, USAF
Alvin Hicks, MSgt, USAF
Michael Mohay, TSgt, USAF
Abstract: Landstuhl Regional Medical Center (LRMC) has experienced a major transformation in the six years since
September 11, 2001. As the Global War on Terror has expanded through OEF/OIF and other contingencies, so have the
medical response capabilities in support of deployed and garrisoned war fighters. The Department of Pathology and
Area Labs (DPALS) at Landstuhl Regional Medical Center (LRMC) has also evolved to meet the changing demand for
increased and more robust support for downrange MTFs as well as expanded services at LRMC. We will present the
unique challenges, roles, and successes of DPALS in response to this expeditionary force structure. We will illustrate
the role of our expanding blood services to include transfusion and blood donor center activities, the challenges of
transforming into a regional referral laboratory center in support of EUCOM, CENTCOM, AND AFRICOM, efforts to
standardize core laboratory operations within European Regional Medical Command, and force health protection support
for EUCOM. We will also present the experiences of integrating and operating as the only Tri-Service staffed clinical
laboratory in DoD.
Objectives:
1. To understand DPALS’ role in the Global War on Terror in support of local, regional, and expeditionary medical
operations.
21
Society Scope
2. To illustrate our strategy for standardization of laboratory services within the European Regional Medical Command.
3. To understand how DPALS has integrated into a successful Tri-Service work environment.
#21 Mentoring from Gray Suits.....
Presenter(s): Michael Caldwell, Col(ret), USAF
Daniel Brown, Col(ret), USAF
Jim Lynette, Col(ret), USAF
Bill Signeous, Col(ret), USAF
Bill Ottinger, Col(ret), USAF
Dave Lyle, CAPT(ret), USN
Tom Robillard, Col(ret), USAF
Chuck Watkins, Col(ret), USAF
Prince of Wales
Abstract: Ever wonder what happened to those who retired? Most of them could not stand to just play golf! Do you ever
question whether or not the experiences and training you developed in the military will translate into the civilian sector?
It most certainly will! This workshop will be presented by several ‘gray haired’ retirees that had the same questions a few
years ago. These individuals have transitioned into the fields of research, education, consulting, laboratory management,
blood banking, human resources, computers and other healthcare and business fields. The objectives of this workshop are
to learn transition skills, pre-retirement preparation, examine the various careers available in the civilian sector that you
already process and most importantly participants will have the opportunity to question successful executives that have
made the transition.
DISCLAMER: THIS WORKSHOP IS NOT DESIGNED TO ENCOURAGE PARTICIPANTS TO LEAVE THE
MILITARY. IT IS DESIGNED TO PROVIDE TRANSITION INFORMATION AND EXPERIENCES ONCE
INDIVIDUALS “HAVE TO LEAVE THE MILITARY”.
Objectives:
1. Realize the talents/expertise they already process that can be transferred to the civilian sector.
2. Participants will have the opportunity to question successful retirees about their transitions after a military career.
3. Learn transitioning tips and requirements for a successful civilian career.
1000-1200 2-Hour Workshops
#22 Molecular Diagnostics for Dummies.....
Presenter(s): G. Shane Hendricks, Capt, USAF
Cambridge
Abstract: Molecular diagnostics is an increasingly pervasive discipline within the clinical laboratory. Unfortunately,
molecular biology is not an easy subject to grasp conceptually, as it doesn’t have much in common with the base of
knowledge underpinning many traditional laboratory assays. Many in DoD clinical labs have attended crash courses in
molecular concepts to meet new readiness and homeland defense requirements, but those courses only scratch the surface
of a field that will become an increasingly routine part of daily laboratory work. The purpose of this short course is to
review basic concepts and scratch a little deeper and expose curious, inexperienced, silently-intimidated laboratorians to
a broader base of knowledge from which to proceed. The course begins with the central dogma of molecular biology,
progresses through basic laboratory protocols, and culminates with current and potential future uses in diagnostics. This
course is intended for laboratorians with a minimal understanding of molecular concepts or to those who want a quick
refresher on the basics.
Objectives:
1. Following the presentation, attendees will be able to summarize the basic aspects and processes of the central dogma
of molecular biology.
22
Society Scope
2. Following the presentation, attendees will be able to describe at least three common protocols used in molecular
diagnostics and research.
3. Following the presentation, attendees will be able to list at least three present or potential future applications of
molecular techniques in the clinical laboratory.
#23 LONG TERM HEALTH EDUCATION & TRAINING (LTHET) AND MICROBIOLOGIST (71A) RESEARCH OPPORTUNITIES.....
Melrose
Presenter(s): Michael T. O’Neil, LTC, USA
Michael P. Kozar, LTC, USA
Abstract: This workshop will provide information and guidance for individuals interested in Long Term Health
Education and Training (LTHET) in microbiology, as well as, information for current 71As on the variety of research
assignments in diverse fields of study for military microbiologists. LTHET graduates and microbiologists, representing
several areas of research, will provide informative information and guidance on the LTHET process, graduate school, and
the various research opportunities. This workshop is designed for individuals interested in becoming 71As and current
MS and PhD level 71As.
Objectives:
1. Discuss strategies for the prospective LTHET applicant to excel in graduate school and transition into military relevant
research.
2. Familiarize participants with the purpose, structure and function of the Military Research and Material Command
(MRMC).
3. Learn about the various types of research conducted by uniformed scientists within the Military Medical Research
Command (MRMC).
#24 cancelled
#25 Air Force Research Laboratory: Using S&T to propel Air Force technological innovation.....
Oak Alley
Presenter(s): Patricia A. Reilly, Col, USAF
David Watson, Maj, USAF
Robin E. Mitchell, Maj, USAF
Abstract: The Air Force Research Laboratory (AFRL) is the science and technology (S&T) arm of the Air Force
acquisition and logistics community. Our mission is to make the Air Force S&T vision a reality by driving innovations
in technology. Located within AFRL’s Human Effectiveness Directorate, the Applied Biotechnology Branch (RHPB)
creates and delivers relevant applied biotechnology & nanotechnology solutions for the battlefield airmen and the
integrated joint services mission. Advances in human effectiveness and performance is achieved through a variety
of biotechnologies, including: genomics, proteomics, metabonomics, bioinformatics, engineering cellular systems
and networks and physiologically-based pharmacokinetic modeling. These research tools are used to develop novel
technologies to identify adverse effects to the warfighter before clinical symptoms arise, thus allowing for early
intervention. This workshop is designed to provide an overview of AFRL’s strategic plan and its three core technology
processes. Current laboratory officers and technicians will provide an overview and update on their research efforts to
include work in, but not limited to, Nanomaterial Toxicity, Biomarker Discovery, Cellular Dynamics and Engineering, and
Human Performance Optimization.
Objectives:
1. Participants will receive an overview of AFRL’s Strategic Plan and its three Core Technology Processes and will gain
an understanding on how current research efforts within the Applied Biotechnology Branch fit within this vision.
2. Participants will gain an understanding on how AFRL’s funding sources (Core, AFOSR, Congressional, SBIR) direct
various research efforts within the Applied Biotechnology branch.
3. Participant will be provided an overview and update on the branches current research, including, but not limited to,
23
Society Scope
efforts in: Nanomaterial Toxicity, Biomarker Discovery, Cellular Dynamics and Engineering, and Human Performance
Optimization.
13 Feb 08 (Wednesday)
1300-1500 2 Hour Workshops
#26 You just bought a new analyzer…now what?.....
Rosedown
Presenter(s): Robel Yohannes, 1LT, USAF
Abstract: Before a new instrument is placed for patient testing, there are several studies that need to be completed. This
presentation explains how linearity study, correlation study, and carry over study are performed. Instrument linearity
defines how high and how low one instrument measures a given analyte accurately with out making dilution. Correlation
study shows how accurate and precise an instrument is by comparing that instrument’s reading with another method/
instrument that is already established. Carry-over study shows how efficient an instrument is in cleaning itself before
every specimen ; thus there is no effect of one specimen run before another. This presentation also delves into CAP
requirements in regards to establishment of new instrument including establishing the analytical measurement range
(AMR).
Objectives:
1. Explain why and how Linearity and correlation studies are performed.
2. Understand AMR and CRR verification.
3. Explain why and how to conduct carry-over study.
#27 Respiratory Tract Infections Review....
Presenter(s): Wade Aldous, LTC, USA
Edward F. Keen, CPT, USA
Brian J. Robinson, 1LT, USA
Magnolia
Abstract: The respiratory tract is one of the major connections between the interior of the body and the outside
environment. Simply by breathing, we are subjected to a wide variety of potentially pathogenic organisms and viruses
everyday that can cause infection. Although, our bodies possess several mechanical and chemical defense mechanisms,
we often become colonized leading to infection. Several wounded and healthy service members and their beneficiaries
will develop a respiratory infection each year. While most of these infections are very common and easily treatable or
preventable, a number of individuals will become hospitalized and require therapy based upon an interplay between
various host and microorganism factors. This workshop will review the various infections of both the upper and lower
respiratory tract, the common pathogenic organisms involved, and methods of laboratory diagnosis of these infections.
Pertinent case studies will be included.
Objectives:
1. Differentiate between upper and lower respiratory tract infections.
2. Review the specific diseases causing both upper and lower respiratory tract infections.
3. Identify common pathogens by site and patient age.
#28 Navigating the Air Force Institute of
Technology (AFIT) Program.....
Presenter(s): Paul T. Barnicott, Col, USAF
Richard Schoske, Lt Col, USAF
Nathan Johnson, Lt Col, USAF
David Lincoln, Maj, USAF
24
Jasperwood
Society Scope
Abstract: The Air Force Institute of Technology (AFIT) selects qualified officers to pursue advanced educational
opportunities to include masters degrees, PhDs and fellowships. The process starts with senior AF leadership identifying
and prioritizing the required skill sets through the Integrated Forecast Board (IFB). Once the available opportunities
are published, qualified officers are encouraged to apply for these educational opportunities. These opportunities have
historically included masters degrees in clinical laboratory science, PhDs in clinical microbiology, and Blood Bank
fellowships to name a few. The participants of the workshop will gain knowledge/learn what goes into the IFB process
and AFIT application process. Furthermore, the workshop will be co-chaired by AF officers who were successful in AFIT.
They will provide the participants with lessons learned that will help future AFIT participants achieve the ultimate goal of
AFIT, graduating with a degree!
Objectives:
1. Recall the AFIT application and Integrated Forecast Board process.
2. Incorporate and use speakers’ lessons learned to assist if chosen for an advanced degree/fellowship.
3. Examine available degree programs and match them to current skill sets and interests.
1300-1730 4-Hour Workshops
#29 Achieving Compliance with CAP Laboratory Accreditation Requirements.....
Fountain Room
Presenter(s): Robert R. Rickert, MD
Ms. Nancy Yeransian
Abstract: Being proactive is more efficient and cost-effective than being reactive. Ensuring compliance and continuously
working to improve processes is better that fixing problems. This session will help you learn from the mistakes of others
by detailing the most frequently cited deficiencies and giving you strategies for not only avoiding them, but ensuring
continuous compliance with the checklist requirements. A major emphasis of the CAP Patient Safety Goals is to improve
the laboratory’s processes by proactively addressing common risks, monitoring activities, responding to incidents and
documenting its evaluations. You will receive practical tips and tools that will assist you in assessing your own lab’s
compliance and improving its processes regarding patient safety goals.
Objectives:
1. List the most frequently cited deficiencies that are common to all checklists.
2. Develop strategies to efficiently and effectively demonstrate compliance with these checklist requirements to avoid
receiving deficiencies.
3. Assess your laboratory’s compliance with the CAP inspection checklist questions that address the Patient Safety
Goals.
#30 Officer Professional Development.....
Presenter(s): Lucia More, Lt Col, USAF
Melrose
Abstract: This workshop is mandatory for all AF lab officers in the ranks of O-3 and below. It is intended to provide
tools for becoming more effective, confident leaders. It is presented by a panel of senior USAF Lab Officers who have
a wealth of valuable experience and information between them. It will cover writing effective OPRs/PRFs, BSC force
structure and career path, rank appropriate education and training to build your career, and developing leadership skills.
Objectives:
1. Understand the BSC officer career path and career development strategies.
2. List the characteristics of an exceptional officer.
3. Learn effective appraisal writing techniques.
25
Society Scope
#31 OERs, ORBs, Promotions, Career Planning, Assignments, Extra Duties, Skill Badges, and other Nuggets.....
Oak Alley
Presenter(s): Helen B. Viscount, LTC, USA
Abstract: This 4-hour workshop will discuss the DA PAM 600-4 life cycle model and MRMC, Clinical, and USAR
specific roadmaps for 71As (microbiologists). The workshop will describe nuggets to set you apart from the competition
and to pick up along the way badges and training such as Airborne, FIBWA and many more. The workshop will also
discuss the Officer Section of AR 623-3 and how to help your Rater and Senior Rater write your OER. Additionally, this
workshop will review DA PAM 640-1 and how to proof and manage your ORB.
Objectives:
1. To familiarize attendee with DA PAM 600-4 life cycle model.
2. To give at least 3 examples of how to help the rater and the senior rater write the attendee’s OER .
3. To describe the different sections of the ORB.
#32 EBTS Deployment 101: Don’t Panic!.....
Presenter(s): Scott A. Corey, Capt, USAF
Robert Curtis, Capt, USAF
Susan L. Andersen, MSgt, USAF
Brian T. Wellborn, MSgt, USAF
Belle Chasse
Abstract: The EBTS was designed and is executed to provide support and sustainment to expeditionary forces. To meet
this requirement, assigned personnel must have the knowledge and training to successfully sustain a deployed medical
force through the full spectrum of military operations. This four hour workshop will describe the distribution of all blood
products in the CENTCOM AOR. The workshop will benefit all who are deployed (or face future deployment) at any Air
Force EMEDS, Army CSH, Navy NEMF, and Army Blood Supply Unit. Discussion will include joint policy concerning
administration of blood components, shipping, receiving, inventorying, storage, and disposition of blood products. In
addition, discussions regarding various key players involved in airlift including Special Handling, Traffic Management
Office, Load Planning, the Air Mobility Division in the Combined Air Operations Center, will be covered. It is imperative
that planners and medical personnel understand logistics and blood distribution processes in order to meet the deployment
and sustainment challenges.
Objectives:
1. Prepare Officers/Enlisted personnel for success in support of the blood mission.
2. Develop a better understanding of the limiting factors associated with blood bank standards and transfusion practices
in a deployed environment.
3. Describe the process by which blood products are distributed in theater and used in direct support of the warfighter.
1530-1730 2 Hour Workshops
#33 CREATING THE LAB INTRANET USING MICROSOFT SHAREPOINT.....
Rosedown
Presenter(s): John Ware, LCDR; USN
Trent K. Freeman, LT, USN
Abstract: Many Navy Medical Facilities are using Microsoft SharePoint as the utility to create the “local” or command
intranet web pages. This workshop will allow the attendees to view how some laboratories have used this technology to
provide effective communication to the hospital and laboratory staff. Using the functionalities present, the attendees will
collaborate to build a laboratory webpage using SharePoint.
26
Society Scope
Objectives:
1. The participants will identify the functionalities of Sharepoint software.
2. The participants will collaborate in creation of a laboratory portal page.
3. The participants should be able to design and build a laboratory portal page.
#34 Transforming Medical Care: Medical Modernization Directorate.....
Magnolia
Presenter(s): Debra Niemeyer, Col, USAF
Timothy G. Wiley, Lt Col, USAF
Bailey H. Mapp, Lt Col, USAF
Steven P. Quigley, Maj, USAF
David W. Hagerty, Maj, USAF
Sean M. Chickery, Capt, USAF
Scott Phillips, MSgt, USAF
Abstract: This workshop is for lab personnel, officer, enlisted, and civil service, who are interested in learning more
about medical modernization, medical care transformation and how the Modernization Directorate (AF/SGR) supports the
joint warfighter. A new directorate stood up in 2003, SGR offers a variety of exciting high visibility, career-enhancing job
opportunities ranging from requirements building, R&D and technology solutions identification, program management,
IM/IT and clinical services support, solutions integration, technology assessment, training and transition. It is presented
by a panel of laboratory personnel assigned to SGR work in different parts of the directorate and have a wealth of valuable
experience and information to share with the audience.
Objectives:
1. Review directorate history and understand why it was stood up.
2. Discuss directorate vision & mission, and each division’s and role in transforming medical care.
3. Highlight modernization programs, benefit to the lab field, and how laboratorians are supporting the modernization
mission.
#35 HOST PARASITE RELATIONSHIP IN A MILITARY SETTING.....
Jasperwood
Presenter(s): Stewart Lipton, PhD
Abstract: The lecture will include the dynamics of host-parasite relationships. A number of examples will be given. On
the host side, a cursory look at how the immune response helps and hinders the parasite. On the parasite side, adaptive
evolutionary mediums will be discussed that help the parasite. With each example various techniques will be discussed
that can avoid parasitism.
Objectives:
1. To understand host response to parasites.
2. To understand parasite adaptability to infect host.
3. To learn techniques to avoid parasitism.
27
Society Scope
2008 SAFMLS SHORT TOPICS AND ROOM ASSIGNMENTS
GROUP ONE:
Grand Salon 21/24
0900 Army Clinical Microbiology Training Development and Professional
Certification Presenter(s): LTC Carl Brinkley & LTC Wade Aldous
Abstract: A recent Force Design Update (FDU) for the next generation CSH designates two each 71A
microbiologists via the AMEDD Professional Filler System (PROFIS) assigned to each of the eleven US
Army Forces Command (FORSCOM) hospitals. Supporting the Army transformation vision, the future
CSH has an expanded humanitarian mission of stability, security, reconstruction and detainee operations for
extended duration. Relevant to the 71A community, FDU solutions to documented capability gaps are now
requirements for (1) the M403 augmentation set (culture/susceptibility testing, rapid microbiology diagnostics)
(2) biological threat agent detection with the JBAIDS real-time PCR platform, and (3) 71A augmentation to
each CSH company for split-based operations. Thus future personnel demands within the 71A officer inventory
require a collection of leaders with clinical microbiology expertise commensurate with this new operational
mission. One solution being considered is a 1 year clinical microbiology internship for 71A officers without
the unique skills associated with a clinical utilization assignment. Associated topics discussed in this seminar
include potential MEDCEN host sites for the internship, target groups/eligibility requirements, inclusion as a
Long Term Health Education and Training (LTHET) non-degree program, options for professional certification
credentials, and sustainment training. One part of the seminar will also address the ABMM fellowship as
another related clinical LTHET opportunity for 71As. Objectives:
1. Describe Army Medical Department (AMEDD) transformation requirements for clinical microbiology
capabilities and officer skill sets within the future Combat Support Hospital (CSH).
2. Present planning ideas for standardization of a 1 year clinical microbiology internship
3. Discuss the post-doctoral fellowship opportunity and American Board of Medical Microbiology (ABMM)
board certification
1000 USAF Education and Training
Presenter(s): TSgt David LaRowe & Capt Paul Nelson
Abstract: This workshop is targeted for USAF Jr./Sr. Enlisted members concerned with the present and future
of Medical Laboratory Training. It is intended to provide current course information, strengths/concerns thru
our most recent course validation and milestones reached from the last U&TW. This workshop is paneled by
current training supervisors/instructors. Additionally, we will provide the most up-to-date info concerning the
schoolhouse relocation to Ft Sam Houston that, under BRAC/ITRO will combine our training w/ the Army and
Navy programs. Lastly, during the Q&A portion, it is our intent to answer questions pertaining to training and
gather feedback from front line supervisors/lab managers, thus assisting us in keeping a finger on the pulse of
current career field concerns.
Objectives:
1. Describe the Enlisted Medical Laboratory Apprentice Program Phase I/II
2. Explain Current Perspectives of MLT Education and Training
28
Society Scope
3. Discuss the Future of USAF 4T0X1 Education and Training Programs
1100 USAF LABORATORY FORCE HEALTH PROTECTION FELLOWSHIP
Presenter(s): Capt Sean Chickery
Abstract: The audience will receive an overview of the Air Force fellowship in Laboratory Force Health
Protection (FHP). Topics include a summary of the fellow’s experience working in the AF Surgeon General’s
Modernization Directorate, overview of various projects that the fellow has been involved in. An overview
of the various FHP tours and site visits will be included. The presentation will conclude with fellowship
application procedures and a brief discussion on FHP follow-on assignments. Objectives:
1. Describe Fellowship applicant requirements and SGR experience
2. Provide overview of desired learning outcomes
3. Describe future duty assignments in force health protection
1130 Force HEALTH PROTECTION
Presenter(s): Major Marybeth Luna
Abstract: The audience will receive an overview of the HQ Air Force Security Forces Force Protection
Innovation Division. Topics include current initiatives in Force Health Protection, Modeling and Simulation,
Non-Lethal Weapons, and Future Capabilities. Participants will also learn how our mission ties in with HAF/
SGR Modernization Directorate’s efforts in future medical capabilities. Examples of current and past initiatives
will be discussed.
Objectives:
1. Discuss the Force Protection Innovation Division’s mission
2. Discuss how projects are solicited, funded, and executed
3. Explain the need for medical expertise in force health protection
GROUP TWO:
Grand Salon 6
0900 THE CHALLENGE OF IMPLEMENTING GOOD LABORATORY PRACTICE IN A SMALL DOD
RESEARCH LABORATORY
Presenter(s): LT Jennifer Evans
Abstract: The Army Medical Command is developing therapeutic solutions for chemical warfare agent (CWA)
poisoning. These solutions require FDA licensure prior to dissemination to troops. Research performed in
support of therapeutic solutions such as new drug applications (NDA), investigational new drugs (IND) or
biologic devices must be performed IAW Food and Drug Administration guidelines and Federal regulations.
The quality system necessary to produce research that meets FDA guidelines and Federal regulations needs
to be implemented in a small, research-oriented DoD laboratory. GLP has not been done prior to this time;
therefore, a Regulated Studies office must be created in order to guide researchers and support staff in this
process. Current peer-reviewed literature addresses this problem as it applies to non-DoD organizations and
universities. Most of the principles and suggestions outlined in these papers are sufficiently general to be
applicable in this situation. (Exact literature references can be quickly obtained).
29
Society Scope
Objectives:
1. Describe how regulatory issues affect everyone, and will not “go away” if ignored
2. Illustrate the necessity of having key players trained and “on board” early as possible
3. Illustrate the necessity for persistence: GLP compliance doesn’t happen overnight
1000 ENHANCING PROCESS IMPROVEMENT WITH PRE-ANALYTICAL ERROR TRACKING
Presenter(s): Capt Patrick Cutter
Abstract: The speaker will discuss the development of an error tracking tool developed for a large civilian
hospital laboratory. The focus will be measuring laboratory pre-analytical error rates and how to use this data
to enhance process improvement. We will also discuss obstacles encountered with emplacing this error tracking
system. The intention of this presentation is to provide fellow laboratorians with an example of a pre-analytical
error measuring method and explain how it was used to provide a positive impact on patient care.
Objectives:
1. Classify specimen laboratory errors as pre-analytical, analytical, or post-analytical.
2. Discuss how to develop and implement a pre-analytical error tracking tool.
3. Describe process improvement with an error tracking tool.
1100 WORK SMARTER, NOT HARDER
Presenter(s): 1ST LT Kasey Jackson
Abstract: Bring your ideas! This is an interactive discussion on ways to improve laboratory performance by
streamlining management processes. Presenter will share ideas of ways to make required tasks easier and more
understandable. Some of the topics discussed will be CAP survey reviews and troubleshooting, patient result
reviews in CHCS and CAP checklist reviews. Attendees are encouraged to share any processes that they know
of to help make laboratory management easier.
Objectives:
1. Discuss the process of CAP survey reviews and troubleshooting to provide guidance and easier methods of
managing this process.
2. Discuss alternatives to the paper system of cumulative reviews of patient results in CHCS.
3. Discuss alternatives for review of CAP checklists- this process will be made easier by going through each
individual question and documenting proof of compliance.
GROUP THREE:
Grand Salon 18
0900 DOD TOXIN DETECTION CHALLENGES IN CLINICAL SAMPLES
Presenter(s): Capt Carlos Maldonado
Abstract: Current DoD toxin detection platform is scheduled to go ‘offline’ by the end of the 2008 calendar
year. Although not ideal, the immuno-based approach to toxin detection and identification in clinical matrices
has provided a 70% mitigation strategy to the real-world threat of biological toxins. Recent market surveys
of commercially available systems suggest an enhanced immuno-based detection capability remains a viable
yet temporary solution to DoD toxin detection capabilities. This session will present and discuss both the
characteristics of naturally occurring and man made toxins as well as the technical challenges involved in real30
Society Scope
world detection and identification in clinical matrices. We will also present and discuss the inherent limitations
of immuno-based toxin detection capabilities, their mitigation strategies (what operators need to know) derived
from scientific research as well as upcoming/proposed solution strategies and alternatives to this capability.
Objectives:
1. Review the nature and occurrence of biological toxins of operational significance.
2. Review technical challenges in toxin detection and ID in clinical samples.
3. Review DoD mitigation strategies and next generation toxin ID and diagnostics systems.
1000 MOLECULAR DIAGNOSTICS FOR DUMMIES
Presenter(s): Capt G. Shane Hendricks
Abstract: Molecular diagnostics is an increasingly pervasive discipline within the clinical laboratory.
Unfortunately, molecular biology is not an easy subject to grasp conceptually, as it doesn’t have much in
common with the base of knowledge underpinning many traditional laboratory assays. Many in DOD
clinical labs have attended crash courses in molecular concepts to meet new readiness and homeland defense
requirements, but those courses only scratch the surface of a field that will become an increasingly routine
part of daily laboratory work. The purpose of this short course is to review basic concepts and scratch a little
deeper and expose curious, inexperienced, silently-intimidated laboratorians to a broader base of knowledge
from which to proceed. The course begins with the central dogma of molecular biology, progresses through
basic laboratory protocols, and culminates with current and potential future uses in diagnostics. This course is
intended for laboratorians with a minimal understanding of molecular concepts or to those who want a quick
refresher on the basics.
Objectives:
1. Following the presentation, attendees will be able to summarize the basic aspects and processes of the central
dogma of molecular biology
2. Following the presentation, attendees will be able to describe at least three common protocols used in
molecular diagnostics and research.
3. Following the presentation, attendees will be able to list at least three present or potential future applications
of molecular techniques in the clinical laboratory.
1100 OVERVIEW OF JBAIDS TRAINING
Presenter(s): James Murray GS-12
Abstract: The Joint Biological Agent Identification and Diagnostic System (JBAIDS) is being fielded
throughout the military, and initial and sustainment training are required to ensure that JBAIDS Operators are
competent to perform the sample analyses and obtain reliable results. The Joint CONOPS requires that all
initial and replacement Operators be school trained, and that personnel and laboratories participate in regular
quality assurance program, usually including proficiency testing. After training of the initial Operators, each
Service is responsible for providing funding for the training of replacement personnel and the proficiency
testing. The JBAIDS Training Program is currently developing computer-based training to use for refreshing
knowledge about JBAIDS operations and kits. These and related topics pertaining to the training program will
be discussed, including points of contact for obtaining funding and approval for training.
Objectives:
1. Describe the JBAIDS training course and the upcoming JBAIDS computer-based training.
31
Society Scope
2. Describe the requirements for training and proficiency testing.
3. Describe avenues for obtaining funding to attend JBAIDS training
1130 eGLIN BAT ROLE IN THE JBPDS OPERATIONAL EVALUATION PHASE VI
Presenter(s): Capt Paul Keown/ SSgt Morgan Briden/ Maj Maria Kohler
Abstract: This presentation will familiarize the audience with the concept of the Joint Biological Point
Detection System, the purpose of the operational evaluation and the Biological Augmentation Team role. It will
focus on the field set-up of the Homeland Defense trailer and environmental sample testing. The attendee will
gain an understanding of the Joint Biological Agent Identification and Diagnostic System field operation and
requirements. Objectives:
1. Summarize the JBPDS concept, operational evaluation phase VI, and the BAT role.
2. Describe the HLD trailer field set-up and operation
3. List the steps of sample testing using JBAIDS
GROUP FOUR:
Grand Salon 15
0900 THE AIR FORCE MEDICAL GENETICS CENTER: SERVING THE ARMED FORCES
LABORATORY COMMUNITY
Presenter(s): Capt Mona Nelson
Abstract: As the only medical genetics center in the Department of Defense, the Air Force Medical Genetics
Center is moving forward to becoming the “Center of Excellence” for all genetic tests providing diagnostic
laboratory service to the Army, Navy, and Air Force facilities. In an effort to ensure optimum utilization of
services, this presentation will educate the Armed Forces laboratory community on the center’s genetic testing
capability, protocols for requesting our services, and the financial benefits of referring genetic tests to our
facility.
This presentation provides:
- An overview of current and future cytogenetics and molecular genetic tests.
- Price comparison between civilian genetic tests and the Air Force Medical Genetics Center.
- Instructions on setting up interoperability, specimen requirements, and shipping.
- Handouts listing all genetic testing capability and points of contact.
Objectives:
1. Describe the mission, organization, and scope of services of the Air Force Medical Genetics Center
2. Illustrate potential cost savings for the referring military lab for utilizing our services versus civilian labs.
3. Explain important components of order requirements, specimens of choice, and shipping protocols.
0930 REGIONAL EMERGENCY PREPAREDNESS LIASON OFFICERS (REPLO)
Presenter(s): LTC Golash
Abstract: The Regional Emergency Preparedness Liaison Officer (REPLO)team is assigned to each Federal
Emergency Management Agency (FEMA) region. The team consists of personnel from the Army, Navy,
32
Society Scope
Marines, Air Force and Coast Guard. The Defense Coordinating Officer (DCO) is the official representative of
the DoD and utilizes the REPLOs to assess, plan and implement plans in support of civilian authorities. REPLO
positions can be filled by Army medical service corps officers who have core competencies in microbiology,
etc. The REPLO team is mobilized in conjunction with FEMA activation to establish consequence management
in case of a terrorist attack or a natural disaster. Objectives:
1. Define REPLO team program
2. Describe the functions of the REPLO team
3. Describe cooperative efforts between the military and civilian authorities
1000 Nuclear terrorism: fact or fiction?
Presenter(s): LTC Golash
Abstract: Nuclear terrorism is a new phenomenon that potentially threatens our existence as a Nation. We
are familiar with strategic and tactical nuclear weapons, but we may not be as familiar with suitcase or rucksack
nuclear bombs. Suitcase nukes are missing from the Russian arsenal and re-appeared with Chechen rebels.
There is credible evidence showing that these nukes are now in the hands of al Qaeda. By connecting the dots,
one can surmise that there is a strong possibility that al Qaeda has pre-positioned nukes on our homeland. How
do first responders react ? How does the Nation mitigate this type of situation? In the final analysis, the question
remains is this fact or fiction.
Objectives:
1. Describe the 3 different nuclear weapons
2. Define a suitcase nuclear weapon and how it can be deployed
3. List the methods of mitigation to avoid a nuclear attack by terrorists
1100 The black plague: historical perspectives and future considerations
Presenter(s): CPT Edward Keen III
Plague is an ancient and well documented disease with several historical references describing epidemics that
are symptomatic of infection with Yersinia pestis. The second plague pandemic, also known as the black death
or great pestilence, began in 1346 and eventually killed 20 to 30 million people in Europe by 1351; over one
third of the European population. The pandemic lasted more than a century and resulted in major political,
cultural, and religious ramifications. Humans can acquire plague through the bite of infected fleas, direct
contact with contaminated tissue, or inhalation. Clinically, infection may present in bubonic, pneumonic, or
septicemic forms. As living conditions and public health practices have improved over the years the plague has
practically disappeared from cities and now occurs mostly in rural and semirural areas, where it is maintained
in wild rodent populations. Given the availability of Y. pestis in these natural reservoirs around the world, its
capacity for mass production and aerosol dissemination, high fatality rate of pneumonic plague and potential
for secondary spread of cases, the potential use of plague as a biological weapon remains a concern. This short
topic will provide an overview of historical plague epidemics, past and potential use of Y. pestis as a biological
weapon, and the techniques used to identify this organism in the clinical laboratory.
Objectives:
1. Review epidemic and pandemic outbreaks of Plague and their association with Yersinia pestis.
2. Describe bubonic, pneumonic and septicemic plague symptoms and disease course.
33
Society Scope
3. Describe the various laboratory tests available for the diagnosis of Y. pestis
GROUP FIVE:
Grand Salon 19/22
0900 RAPID MRSA RESULTS FOR PRE-ADMISSION SURVEILLANCE
Presenter(s): Capt Fairlight Reese
Abstract: A mid-size hospital’s evaluation of the cost of Methicillin Resistant Staphylococcus Aureus (MRSA)
treatment and the pre-screening of patients admitted to the hospital. MRSA has made a shift from having a
higher presence in the hospital setting to that of our communities. Patients from the community colonized with
MRSA are potentially going to spread MRSA to other patients in the hospital. The costs for treating healthcare
acquired MRSA is expensive. By pre-screening patients, they can be placed in isolation prior to admission.
Real-time PCR of MRSA allows the laboratory to provide a quick result to the ward allowing hospital staff to
place the patient in the right type of room (standard or isolation). Potentially a mid-sized hospital’s laboratory
is not large enough to warrant PCR routinely for labs. However, Cepheid’s GeneXpert allows on-demand realtime PCR which requires little preparation to the sample prior to amplification.
Objectives:
1. Discuss background on MRSA Surveillance
2. Describe Real-time PCR for MRSA in the hospital setting
3. Explain hospital cost savings by pre-admission screening for MRSA
0930 adenovirus b-14 outbreak, lackland air force base
Presenter(s): Lt Col Samuel “Phil” Livingstone
Abstract: Respiratory disease outbreaks are a common occurrence in military training populations. The
Epidemic Outbreak Surveillance (EOS) Program was established to develop and test leading edge technologies
to reduce the diagnostic time of bacteria and viruses causing influenza like infections (ILIs) which, if not
contained, may contribute to respiratory disease outbreaks. From March through July 2007, Lackland Air Force
Base experienced a significant rise in ILIs caused by Adenovirus type B14. The purpose of this short topic is
to discuss EOS’s contribution to the management of this increased number of ILIs, the technology used and
challenges encountered when tools being developed by a research program are requested to support a real world
event.
Objectives:
1. Discuss the impact of outbreaks in military training populations and characteristics of adenovirus B14 in this
specific event
2. Describe the Epidemic Outbreak Surveillance Program contribution to the Adenovirus type B14 outbreak
3. Define the challenges when trying to apply a research developed technology to a real world event
1000 yersinia pestis- pathogenicity, vaccine and vaccine development
Presenter(s): LTC David Heath
Abstract: An overview of the pathogenicity of Yersinia pestis (plague) infection will be presented to include
vector transmission from the flea to humans with subsequent bacteremia and multiple organ involvement to the
end stage pneumonic form. Two of the prominent virulence factors of Yersinia pestis, the F1 capsule and the V
34
Society Scope
antigen, will be discussed along with a depiction of how the F1-V fusion protein was constructed to compose
USAMRIID’s current plague vaccine. Several slides will be shown to demonstrate the efficacy of the F1-V
plague vaccine in different animal models followed by a discussion of the requirements for an investigational
new drug application. This discussion will include the “two animal rule” as well as assay development for a
correlate of immunity assay used to predict immunity or protection
Objectives:
1. Describe the pathogenesis of Yersinia pestis infection and prominent virulence factors
2. Demonstrate how the recombinant vaccine to Yersinia pestis was constructed and its efficacy in animals
3. Discuss how vaccines are developed to include product development and investigational new drug
development application
1030 zoonotic infections
Presenter(s): LTC Wade Aldous
Abstract: Zoonoses, diseases transmitted through or from animals to humans, are responsible for a large and
growing proportion of the mortality and morbidity throughout the world. These infections from pets or wildlife
exposure, whether via bites or casual contact, can have a significant effect on humans. They typically affect
the respiratory tract, skin and soft tissues, the central nervous system (CNS), and even systemically in the
bloodstream. There are more than 200 known zoonotic infections of which the majority are bacterial in nature.
Many of these agents are emerging or re-emerging due to our increased risk of exposure to them. The reasons
for the increase are varied: dietary changes due to large scale industrial food processing, and development of
fast food restaurants; increased animal populations, leisure activities (hunting, fishing, tourism); degradation
of the natural environment to cause relocation in urban areas. Additionally, human immunosuppression;
and increases in antibiotic resistance lead to greater disease burden. This workshop will discuss the common
bacterial zoonotic infections, clinical manifestations, mechanisms of pathogenesis, and laboratory diagnosis.
Pertinent case studies will be presented for review. Objectives:
1. Discussthe various bacterial diseases that can come from working and living around animals
2. Identify common reservoirs and vectors, pathogenesis and sites of infection of bacterial zoonoses
3. Review the causative organism for several zoonotic diseases and laboratory diagnosis
1130 combatting hiv: An arsenal of new weapons
Presenter(s): David Escamilla GS-11
Abstract: The dire pervasiveness of HIV infection among today’s population has given rise to an onslaught
of strategies in both the military and nonmilitary communities to attack this problem from multiple angles. The
Air Force Epidemiology Lab, for example, tests almost two thousand patients a day for HIV reactivity in order
to facilitate early detection. And given the fact that 40 million people harbor the virus, public health institutions
are constantly striving to promote exposure prevention. Meanwhile, scientists worldwide continue to search
desperately for an effective vaccine. However, some of the most notable advances in the battle against HIV are
taking place in the area of pharmaceutical research. Recent discoveries hold the potential for deferring the onset
of disease in some patients by years or even decades.
This presentation will review some of the progress made in the realm of HIV drug development, including
the introduction of fusion inhibitors, maturation inhibitors, and two cutting edge drugs which just received
35
Society Scope
FDA approval within the last six months. The presentation will explain the mechanisms by which various
drugs suppress HIV and will shed light on their efficacy and side effects. It will discuss cost and other factors
affecting the widespread availability of HIV drugs. And it will explore the relationship between highly active
antiretroviral therapy (HAART) and the inexorable challenge of drug resistance.
Objectives:
1. Describe the mechanisms by which traditional HIV drugs inhibit viral replication
2. Describe the mechanisms by which several new drugs suppress HIV.
3. Explain the effect of drug resistance on the management of HIV infection
GROUP SIX:
Grand Salon 13
0900 Down’s syndrome maternal screening program at landstuhl regional
medical center
Presenter(s): LTC Aziz Qabar
Abstract: Maternal screening for Down’s Syndrome is an evolving field that continues to draw attention and
sometimes controversy to prenatal screening. The Triple Marker assay is a screening tool to determine the risk
of pre-disposition to genetic defects based on patient’s demographics and the analysis of three serum markers.
The Triple Marker Maternal Screening Program at Landstuhl Regional Medical Center (LRMC) has been
operational for the last 11 years serving military communities in Germany, Italy, Great Britain, Portugal, and
Turkey. According to a recent College of American Pathologists (CAP) report, 50% of laboratories providing
maternal screening still offer the triple marker screening. The latest American Association of Obstetrics and
Gynecology (ACOG) meeting recommended that at a minimum, expecting mothers should be offered the Quad
test during the second trimester. The main objective of the switch to the Quad test is to increase the detection
rate at a constant screen positive rate (sometimes called false positive rate). The Quad test offers a slightly
higher detection rate (~80% at a constant screen positive rate of 5%) than the Triple Marker test (~70%).
However, most Health Management Organizations (HMOs) use this test to reduce the false positive rate, and
henceforth, lessen the extra expenses associated with follow up, more complex genetic testing. LRMC has
made the decision to add the fourth marker to the Triple Marker screen not to reduce the false positive rate
(currently at around ~4 %) but to increase the detection rate and provide Health Care Providers the necessary
tools to make an informed decision about further testing
Objectives:
1. Discuss maternal screening in the second trimester
2. Discuss the reliability of maternal screening in detecting congenital defects
3. Describe establishing maternal screening program in a Medical Center
1000 does the beckman coulter vsc cube provide predictive capability?
Presenter(s): MAJ David Sartori
Abstract: Does the Beckman Coulter VSC Cube provide predictive capability? New studies are showing that
the VSC cube may hold a vast amount of predictive capability. Specific patterns may demonstrate a disease state
or the presence of platelet clumps. Throughout the presentation of examples will be shown. This is a relatively
new concept so open discussion is expected. Could this help medical technologists and pathologists review
peripheral smears?
36
Society Scope
Objectives:
1. Describe and explain the function of the Volume, Scatter, Conductivity Cube.
2. Present examples that demonstrate potential predictive capability.
3. Discuss the potential usefulness
1100 microbiology in a minute
Presenter(s): CPT Vanessa Melanson
Abstract: Whether at the research bench or the hospital laboratory, in the field, or the program office, Army
Microbiologists make significant contributions to the rapid development of science and technology. This
workshop will provide a brief overview of the various projects currently managed by the 71As. and will
demonstrate our state-of-the-art capabilities as well as future clinical and research missions of the Army
Microbiologist.
Objectives:
1. Gain a better understanding of research conducted by Army Microbiologists
2. Understand how this research translates into products for the Warfighter
3. Become familiar with the funding mechanisms for Army research
GROUP SEVEN:
Grand Salon 16
0900 success strategies in a joint venture laboratory
Presenter(s): Capt Jerome Vinluan
Abstract: In this day and age, our budgets can’t always support our increased taskings to successfully meet
a laboratory’s mission. One solution to overcome this challenge is the Joint Venture strategy, where two
organizations utilize cost and resource sharing to meet each other’s needs. In this particular setting we will look
into the Air Force and Veteran’s Affairs joint venture laboratory at Nellis Air Force Base, Nevada.
In theory it may appear this concept is a fool-proof plan to develop a symbiotic relationship between two
organizations with mutual goals. However, there are multiple challenges that must be overcome by lab
management to enable the joint venture to be truly synergistic in nature. This presentation will discuss success
strategies to ensure the joint venture concept thrives in a clinical laboratory setting.
Objectives:
1. Present an overview of the structure of a joint venture laboratory.
2. Discuss the challenges and benefits of a joint venture set up.
3. Describe strategies and tips to overcome these challenges.
0930 USAFE LAB CHALLENGES
Presenter(s): SSgt Robert Murray
Abstract: This workshop is targeted at mid to senior NCOs and junior officers. It is intended to provide
an overview of some of the many challenges facing laboratories in OCONUS locations. It is presented by
experienced NCOs that have dealt with some of the many challenges and overcome them. This workshop will
cover dealing with host nation issues including blood products and supplies, relations with local laboratories,
use of reference facilities, lab result interpretations, equipment, and vendor issues.
37
Society Scope
Objectives:
1. Discuss aspects of laboratory management commonly encountered in USAFE labs
2. Explain the requirements of host nation labs vs US labs (i.e. measurement units)
3. Describe shipping challenges faced by AF laboratories in USAFE
1000 the new balad air force theater hospital
Presenter(s): Capt Denise Lennon
Abstract: AEF 9/10 is the first rotation to be housed in a fixed facility after moving out of the tents. Many
of the challenges faced in the tents such as dust contamination limited electricity, noise, wind, and lack of
space have been resolved. A new set of challenges has arisen. The challenge of remaining a cohesive team in
place for traumas in a facility that looks like home, is a struggle. The 332d EMDG blood bank is the busiest
in the DoD. How the staff manages to issue huge volumes of blood products with absolute minimal errors is a
well orchestrated symphony of flying test tubes, blood, plasma, platelets and paperwork. There is now a shift
occurring, away from an emergent care mindset to one of more definitive treatment. Providers are requesting
more elaborate testing while still needing <5 turn around time for trauma cases. How does this impact
laboratory operations, and what will future capabilities be? Objectives:
1. Describe the new Air Force Theater Hospital in Balad Iraq including capabilities and layout
2. Recall laboratory contingency operations. Discuss trauma versus stable and long-term care.
3. Recognize challenges faced during AEF 9/10 and solutions implemented
1030 NOVEL GLOBAL PROFILE DATABASE TO BLOOD DONOR’S IDENTITY, HEALTH AND
TRAVEL HISTORY
Presenter(s): MAJ Ileana Hauge
Abstract: The Global Profile Database to Blood Donor’s Identity, Health, and Travel History project
innovative idea was funded by the Office of the Secretary of Defense (OSD) under the Phase I Small Business
Innovation Research (SBIR) and Small Business Technology Transfer (STTR). The principle objectives of this
project was to design, develop, compare, test, and identify the best prototype versions for developing the final
Blood Donor medical device product, for global profile database software applications in both military and
civilian sectors of high interest and demand. The top four projects were sponsored by: CAMRIS International
Inc. in collaboration with WYNDGATE TECHNOLOGIES; Intelligent Automation, Inc. (IAI); Knowledge
Based Systems, Inc. (KBSI); and Medical Decision Logic, Inc. (MDL). SBIR Phase I efforts demonstrated
each team’s capability for technological innovation, developing new commercial products, processes, and
services to benefit the government and/or the public. The best system(s) will have the potential to empower
the Blood Donor facility, including the Department of Defense (DoD) to verify and protect donor identity,
access all previous donation information for every donor, automatically flag donors with temporary or
permanent deferrals, verify and update overseas travel history, with built-in continual updating flexibility tools
for mandated FDA changes. More benefits of the Global Donor medical device database future technology
applications include tracking of infectious disease test results across facilities; tracking infectious diseases and
accident data at national scale; component production oversight and blood inventory management in cases
of national security emergencies; tracking imported donations from NATO allies when deployed in theater to
manage mobile blood donations and transfusions.
38
Society Scope
Objectives:
1. Describe Small Business Innovation Research (SBIR) and Technology Transfer (STTR)
2. Develop research knowledge to examine critical national security strategies and best national collaboration
3. Explain SBIR process to identify the most intelligent and innovative idea development into a final product
1130 WARM STORAGE OF WHOLE BLOOD
Presenter(s): Karen Jenkins/ Capt Robert Curtis
Abstract: In field emergency medicine fresh whole blood units are stored at room temperature up to 24 hours
then discarded. Few data exist on the rate of loss of function of the components of whole blood beyond 24
hours. Ten CPD whole blood units were collected and divided into two equal volumes. One half of each unit
was stored at 19°C and the other was stored at 25°C encompassing the accepted range for room temperature
storage. At 6, 24, 48, and 72 hours aliquots were collected from each unit and whole blood analyzed for cell
counts, gases and clotting function using thromboelastography, red cells for intra cellular analytes, platelet
rich plasma for aggregometry and the supernatant for potassium, glucose, lactate and plasma clotting studies.
Results demonstrate that whole blood units stored at room temperatures maintained cellular counts and
coagulation activity for up to 72 hours. Units stored at 19°C demonstrated greater RBC ATP and DPG content
and stronger responses in platelet aggregation studies when compared with 25°C storage. No significant
hemolysis was observed and no bacterial growth was detected. We conclude that storage of whole blood at
room temperature for 72 hours accelerates changes in ATP/23DPG, but the compromise in platelet function
and plasma factors is of such proportion that it would not be expected to be clinically material. This information
suggests that whole blood storage times can be extended prior to component processing and in field expedient
transfusion.
Objectives:
1. Explain the changes whole blood undergoes when stored at room temperature
2. Provide data to support modifications to whole blood storage policies when necessary
3. Present need for use of whole blood in theater
GROUP EIGHT:
Grand Salon 3
0900 amedd acquisition in oif
Presenter(s): LTC Rex Berggren
Abstract: In an effort to identify and solve capability gaps in OIF, the Army deploys four acquisition experts
on a Field Assistance in Science and Technology (FAST) Team. The team is composed of an Acquisition Corps
Team Leader, an acquisition trained civilian engineer, a team NCOIC, and an AMEDD Acquisition Officer.
This team works with senior leadership in OIF to find solutions for issues indentified as quickly as possible. In
addition, serves as a liaison for stateside laboratories under Research, Development, and Engineering Command
(RDECOM) and Medical Research and Material Command (MRMC) to test equipment/items being developed
for Soldiers in the field. This Short Topic will give a brief Army and AMEDD acquisition overview, address
current initiatives in OIF and stimulate discussion about future deployment and employment opportunities.
Objectives:
1. Provide an overview of AMEDD Acquisition
2. Highlight ongoing acquisition projects in OIF
3. Discuss interest in AMEDD acquisition
39
Society Scope
1000 field assistance in science and technology team (fast): deployment
opportunity for ameedd officers
Presenter(s): LTC Karen Kopydlowski
Abstract: The mission of the Research, Development & Engineering Command–Field Assistance in Science
and Technology (RDECOM-FAST) Team is to identify capability gaps in theater and provide a direct link to
the research & development commands, laboratories, and activities to facilitate development and expedite
technology solutions to the warfighter. FAST Teams have deployed to OIF since 2003, but the introduction
of an AMEDD officer to focus on the medical technology mission did not begin until 2005. Since that time,
we have deployed a range of officers such as microbiologists, biochemists, a veterinarian, a physician, and a
clinical laboratory officer. One of the most significant aspects of the FAST team’s mission is to circulate on the
battlefield and pulse units for their technology gaps. The battlefield is a dynamic environment and the only way
to ensure the right technologies are getting to the soldier is to stay engaged. The FAST Team serves as a liaison
between the units and the research & development community to communicate the needs and define the
requirements. For most medical technology needs, we cannot always respond as rapidly to expedite solutions
to the battlefield. Medical products and devices require FDA approval for use – a process that requires years,
so oftentimes we help to get commercially-available FDA-approved products into our inventory. Once we
deliver a solution – whether it’s a developmental prototype or a commercial product – we conduct an in-theater
assessment and obtain feedback to relay back to the R&D community. Sometimes, there are several iterations
of spiral development before we arrive at a solution. This presentation will focus on the medical mission of the
FAST Team and will highlight medical projects and recent successes. As an opportunity open to all AMEDD
officers, a discussion of the candidate selection process, FAST orientation training program, and experiences in
theater will also be presented.
Objectives:
1. Present the mission of the Research, Development, and Engineering Command (RDECOM) Field Assistance
in Science and Technology (FAST) Team, with an emphasis on the medical mission
2. Describe the organizational structure and function of RDECOM and the US Army Medical Research and
Materiel Command and it’s support to the medical mission of the FAST Team for current operations
3. Present the FAST Team projects and recent successes in current operations
1030 a look at an assignment to the 1st aml
Presenter(s): CPT Sarah Pierson
Abstract: This short topic is targeted toward Army laboratory officers in the AOCs 71A, 71B, and 71E
as well as enlisted members in the 68K MOS who are interested in learning more about an assignment to of one
of the Army’s two field deployable chemical, biological, and radiological detection laboratories. Presented by
the senior members of the 1st Area Medical Laboratory’s Endemic Disease section the presentation will focus
on the basic technologies employed by the squad and discuss the laboratory and field skills that are developed
over the course of an assignment to the unit. The presentation will also discuss the professional experience of
moving from a TDA hospital or research institute environment to a small, mobile TO&E preventive medicine
field unit.
Objectives:
1. List the different laboratory officer and enlisted positions available in the Army’s two Area Medical
Laboratories
40
Society Scope
2. Describe the experiences of new section OICs and NCOICs to the unit
3. Discuss technology and testing capabilities of the Endemic Disease section of the 1st AML
1100 first time ncoic/oic?
Presenter(s): 1st LT James “Brian” Clark
Abstract: This seminar is targeted for laboratory personnel who are new NCOs or CGOs and filling the
role of NCOIC &/or OIC for the first time. Intended tools will include strategies for, but not limited to, staff
management, asset management, facility management, accreditation inspections, and self/team involvement at
the Group and Wing levels, respectively. Additional discussion will be given regarding PCS movers to smaller
facilities from large ones whose responsibilities are often newly incurred. A potpourri of laboratory topics will
be discussed and through collaborative discussion, attendees will garner the tools necessary to make educated
and compliant decisions on many laboratory related issues.
Objectives:
1. Discuss management tools for accreditation, staffing, assets, and facility management
2. Identify and discuss role and responsibility for new personnel in laboratory leadership positions
3. Explain the importance of networking with various military functions, local community, and AF/DoD peers
GROUP NINE:
Grand Salon 4
0900 Dealing with UNruly patients
Presenter(s): Tobias DeLong/Christopher Hill/Sarah Long
Abstract: Anyone who has ever had to perform phlebotomy on a patient has had to deal with an upset patient.
No one likes to have a needle stuck in there arm even if it is for their own benefit. Every laboratory needs to
have a process in place to help the phlebotomist deal with an aggressive patient. As a professional you never
want to get in an argument with a patient and you never want to end up in an unsafe situation. This training will
show the value of not confronting the aggressive patient. The training will also demonstrate ways of notifying
fellow workers without the knowledge of the unruly patient. All laboratories need to have a plan in-place that
allows the phlebotomist a safe way in dealing with unruly patients
Objectives:
1. Discuss the potential for aggressive patients and ways to be ready before the patient is in the phlebotomy
area.
2. Describe how to approach an aggressive patient and the steps to take in dealing with the unruly patient that
ensures all workers safety.
3. Implement a work center plan for dealing with aggressive patients.
0930 Defining and tracking critical values at the hospital level
Presenter(s): CPT Holly Swartz
Abstract: In response to National Patient Safety Goal 2C, hospital laboratories were faced with the challenge
of implementing a system to measure and assess, and if appropriate, take action to improve the timeliness of
reporting, and the timeliness of receipt by the responsible licensed caregiver, of critical test results and values.
This short topic presentation will discuss how Irwin Army Community Hospital (IACH) at Fort Riley, KS
41
Society Scope
was able to meet this National Patient Safety Goal with respect to laboratory critical values. In particular, the
presenter will showcase how several senior members of the hospital staff from a variety of disciplines were
involved in developing a hospital-level Critical Value Policy, that included direct reporting of critical values
to the responsible, licensed provider (physician, nurse practitioner, nurse midwife or physician’s assistant) and
a thorough review of the values that were considered ‘critical’ at IACH. The presenter will also discuss the
tracking and reporting of critical values from the time the order is placed to the time the result is received and
reported to the responsible provider. The audience will see the system being used at IACH to meet current Joint
Commission and CAP requirements.
Objectives:
1. Discuss critical value definitions, reporting and tracking as they relate to current CAP and JC requirements.
2. Develop a Strategy for different schedules for randomly assigning QC, what happens to that ‘time to detect’
when you’re out of control? Is it better or worse?”
3. Explain why If you are conducting QC testing three times a day at fixed intervals, and you have one time
when the system goes out of control, randomly picked in a 24-hour period, basic probability theory will tell
you that, on average, it will be four hours before that problem will be picked up at the next QC event.
1000 Improving Organizational Culture Within your laboratory
Presenter(s): 2nd LT James Taylor
Abstract: An organization, like the building that houses it, cannot exist without a quality framework and foundation. Our laboratories are full of the latest advances in instrumentation; however without a quality work
environment, even the best technology is for naught. Organizational culture comprises the attitudes, experiences, beliefs, and values of an organization. Leaders who actively cultivate a positive culture achieve increased
production, dedicated employees, common goals, and reduced turnover. Those who do not take an active
interest risk poor performance, poor decision-making, very high levels of dissatisfaction, and employee stress
well beyond normal workload issues. This class discusses various definitions of organizational culture, why the
culture matters, tips for improving it in your organization, frequently encountered reasons for resistance, and the
benefits of positive change.
Objectives:
1. Discuss what Organizational Culture entails and why it is important
2. List Tips for improving Organizational Culture from the standpoints of communication, collaboration, ethics,
and leadership.
3. List Reasons for resistance when attempting to implement cultural changes and the benefits of overcoming it
1030 QC testing schedule strategy
Presenter(s): SSgt Richard Minton
Abstract: Without random QC performance times, operators are unaware of an instrument with a part that’s
gradually failing, or that’s sensitive to certain cyclical changes in the environment, such as humidity or the
temperature rising as the day goes on. For example, the event occurs at noon every day and only lasts for
one hour. If QC is only performed at 4 PM, you have zero chance of detecting it. It is impractical to take
into account all of the various possibilities, so for purposes of this study our lab research assumed that outof-control events would persist until at least the next QC event. Since we were conducting QC testing once
a day at a fixed interval, and you have one time when the system goes out of control, randomly picked in our
12-hour period, basic probability theory will tell you that, on average, it will be four hours before that problem
42
Society Scope
will be picked up at the next QC event. The question is when you are looking at several different schedules
for randomly assigning QC, when is the best ‘time to detect’ when an analyzer is out of control? Is it better or
worse than the established once per day?”
Four different strategies for QC testing schedules were examined:
• Strategy 1: QC events scheduled at fixed time intervals.
• Strategy 2: QC events randomly scheduled within fixed time intervals.
• Strategy 3: QC events scheduled at random intervals.
• Strategy 4: QC events scheduled at a random interval, followed by a series of n QC events scheduled at fixed intervals.
The average interval between QC events was set at two hours for all of the evaluated scheduling strategies.
Objectives:
1. Explain the need for random use of QC material to detect mechanical errors
2. Discuss the principles and fundamentals of the ICP/MS.
3. Describe Risk analysis, warfighting and Homeland Defense Capabilities.
1100 MAKING NSPS WORK FOR YOU
Presenter(s): CPT Anne Sterling
Abstract: The goals of NSPS are to advance DoD’s critical national security mission, respond swiftly and
decisively to National security threats and other missions, accelerate DoD’s efforts to create a Total Force, retain
and attract talented and motivated employees committed to excellence, compensate and reward employees
based on performance and mission contribution, and expand DoD’s ability to hire more quickly and offer
competitive salaries. That said, it is a new, confusing, and potentially stressful transition to make for civilian
employees and military raters alike. Make NSPS work for you in your lab and community to build your team,
and compensate them for the continued good work they do. The European Regional Medical Command
participated in Spiral 1.3 of NSPS implementation which began on 15 April, 2007. This cycle completes on 31
October 2007, with the first “payout” to occur January 2008. The goal of this presentation is to present lessons
learned and potential tools for use in the application of NSPS to the civilian work force. Some questions that
will be addressed include: Is NSPS more fair and objective than the past system? Will it be harder to write
inflated ratings? Will it be harder to counsel and write ratings, period? Does NSPS tie monetary rewards to
performance and/or step increases? Is it user-friendly to the rater/ratee? How much more/less involved is the
support form/counseling process?
Objectives:
1. Discuss the concepts of rumor control and effective counseling relative to NSPS
2. Explain the timeline and flow for civilian employee counseling and evaluation in the new system
3. Describe performance plans, reviews and evaluations and - the payout process
GROUP TEN:
Grand Salon 9/12
0900 AIR FORCE DEPLOYEMENT WITH THE NAVY IN SUPPORT OF “PARTNERSHIP FOR THE
AMERICA’S” HUMANITARIAN AND TRAINING MISSION
Presenter(s): SMSgt Steven Foster
Abstract: This workshop is targeted for all military laboratory technicians who are interested in learning about
43
Society Scope
a recent Air Force deployment on a USN Hospital ship in a joint environment. It is intended to identify the
unique similarities and differences, expectations and realities when an Air Force laboratory technician deploys
on a four month, 12 country Humanitarian and training mission aboard the USNS Comfort.
Objectives:
1. Identify laboratory testing constraints during the mission
2. Discuss roles and responsibilities assigned to lab technicians
3. Identify overall mission impact
1000 just–in-time training for the deploying reservistS
Presenter(s): SSG Aaron Payton
Abstract: Reservist laboratorians scheduled for deployment have unique needs. Many of them may not work
in healthcare as civilians, and desire some refresher training. AMEDD Center and School has provided JustIn-Time training for several deploying units, customized to meet their requests for refresher training. This
presentation will share with you their most requested topics, most often asked questions, and review issues that
support or impede their progress. Objectives:
1. Discuss the professional concerns of deploying reserve laboratorians and how Just-In-Time training
addresses these concerns.
2. Describe what topics and to what levels of detail are presented for deploying reserve laboratorians.
3. Summarize anecdotal evidence of how well this training met needs and what additional issues were
discovered upon arrival on station
1030 biological detection military-civilian initiatives
Presenter(s): Lt Col Karen House
Abstract: This short topic will introduce attendees to the CBRN Installation Protection Program (IPP).
The CBRN IPP constitutes one of DoD’s first efforts to field a full spectrum of CBRN installation protection
capabilities to military installations and DoD-owned or leased facilities. Fielding a program such as this has its
challenges in a world where policy is still being written. This has led the staff to reach out to other agencies and
build bridges in mil-civ cooperation. These initiatives include partnering with BioWatch and hosting a Best
Practices Working Group. The IPP has fielded biocollectors. Because of the need for testing these samples,
JPMG has continued to operate a testing facility for DFU samples. The procedures used for operating the
BioAnalysis Facility will be discussed and an overview of the various other components of the IPP will be
accomplished.
Objectives:
1. Describe CBRN IPP initiatives in Mil-Civ interaction
2. Discuss the need for Increased awareness of Assets/Resources in Bioanalysis
3. Explain the CBRN IPP Bioanalysis Process
1100 the smartleish in vitro diagnostic device: from benchtop to market
Presenter(s): Lisa Hochberg
Abstract: The differential diagnosis of cutaneous leishmaniasis (CL) has historically relied on the laborious
44
Society Scope
and sometimes tenuous processes of microscopy, culture and iso-enzymatic characterization. Following
the initial stages of Operations Enduring and Iraqi Freedom in 2001 and 2002, when significant numbers of
American personnel began arriving in South West Asia (SWA), the DOD became inundated with thousands
of cases of CL, mostly caused by Leishmania major. This somewhat overwhelming situation highlighted the
need for a faster, more sensitive and specific method for diagnosing CL. To this end, in 2003 the decision was
made to transition a Leishmania detecting, research grade real-time PCR assays that had been developed at
WRAIR for use in a molecular diagnostics branch of the CAP-accredited Leishmania Diagnostic Laboratory
at the Walter Reed Army Institute of Research (WRAIR). At this same time, the need for an FDA-cleared,
commercially available real-time PCR kit for the diagnosis of CL caused by L. major was recognized. This
kicked off a multi-year collaboration between the US Army and Cepheid, Inc. of Sunnyvale, CA, the end
result of which will be the SMART Leish® diagnostic kit. The purpose of this presentation is to introduce the
components, methodology, and testing algorithm of the kit to the broader DOD medical laboratory community.
The kit will be intended for use on the version 2 of the Cepheid SmartCycler®, and is for the qualitative
detection of Leishmania spp. (using a region of 16S rDNA) and for the differentiation of L. major DNA
(within the glucosephosphate isomerase gene) in skin lesion scrapings and punch biopsies from individuals
suspected of having cutaneous leishmaniasis. The kit contains lyophilized beads that, when reconstituted with
molecular biology grade water, will provide the reagents necessary to perform three different PCR tests on each
clinical sample (one assay for Leishmania genus level identification, one for detection of L. major, and a third
internal positive control assay to monitor for PCR inhibitors. Currently, we anticipate the availability of the
kit sometime in fiscal year 2008, and hope that this will have a dramatic positive impact on the ability of DOD
clinical laboratories to quickly report accurate diagnoses of CL to patients and physicians. Objectives:
1. Briefly discuss the recent history of leishmaniasis in military personnel participating in Operations Enduring
Freedom and Iraqi Freedom
2. Describe the SmartLeish in vitro diagnostic device for cutaneous leishmaniasis to the DOD medical
laboratory community
3. Explain how the device will impact the way in which the DOD diagnoses leishmaniasis in military personnel
45
46
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
*US5RRP
*URXS
*UDQG
6DORQ
*URXS
*UDQG
6DORQ
6KRUW7RSLF7LWOH
$UP\&OLQLFDO0LFURELRORJ\7UDLQLQJ'HYDQG3URIHVVLRQDO&HUWLILFDWLRQ
86$)(GXFDWLRQDQG7UDLQLQJ
86$)/DERUDWRU\)RUFH+HDOWK3URWHFWLRQ)HOORZVKLS
)RUFH+HDOWK3URWHFWLRQ
7KH&KDOOHQJHVRILPSOHPHQWLQJ*/3LQDVPDOO'2'5HVHDUFK/DE
(QKDQFLQJ3URFHVV,PSURYHPHQWZLWK3UH$QDO\WLFDO(UURU7UDFNLQJ
:RUN6PDUWHU1RW+DUGHU
'2'7R[LQ'HWHFWLRQ&KDOOHQJHVLQ&OLQLFDO6DPSOHV
0ROHFXODU'LDJQRVWLFVIRU'XPPLHV
2YHUYLHZRI-%$,'67UDLQLQJ
(JOLQ%$75ROHLQWKH-%3'62SHUDWLRQDO(YDOXDWLRQ3KDVH9,
86$)0HGLFDO*HQHWLFV&WU6HUYLQJWKH$UPHG)RUFHV/DE&RPPXQLW\
5HJLRQDO(PHUJHQF\3UHSDUHGQHVV/LDLVRQ2IILFHUV5(3/2
1XFOHDU7HUURLVP)DFWRU)LFWLRQ"
7KH%ODFN3ODJXH+LVWRULFDO3HUVSHFWLYHVDQG)XWXUH&RQVLGHUDWLRQV
5DSLG056$5HVXOWVIRU3UH$GPLVVLRQ6XUYHLOODQFH
$GHQRYLUXV%2XWEUHDN/DFNODQG$)%
<HUVLQLD3HVWLV3DWKRJHQLFLW\9DFFLQHDQG9DFFLQH'HYHORSPHQW
=RRQRWLF,QIHFWLRQV
&RPEDWWLQJ+,9$Q$UVHQDORI1HZ:HDSRQV
'RZQ
V6\QGURPH0DWHUQDO6FUHHQLQJ3URJUDPDW/DQGVWXKO5HJ0HG&WU
'RHVWKH%HFNPDQ&RXOWHU96&&XEH3URYLGH3UHGLFWLYH&DSDELOLW\"
0LFURELRORJ\LQD0LQXWH
6XFFHVV6WUDWHJLHVLQD-RLQW9HQWXUH/DERUDWRU\
86$)(/DE&KDOOHQJHV
7KH1HZ%DODG$LU)RUFH7KHDWHU+RVSLWDO
1RYHO*OREDO3URILOH'DWDEDVHWR%ORRG'RQRU
V,'+HDOWK7UDYHO+LVWRU\
:DUP6WRUDJHRI:KROH%ORRG
$0(''$FTXLVLWLRQLQ2,)
)LHOG$VVLVWDQFHLQ67)$67'HSOR\PHQW2SSIRU$0(''2IILFHUV
$/RRNDWDQ$VVLJQPHQWWRWKHVW$0/
)LUVW7LPH1&2,&2,&"
'HDOLQJZLWK8QUXO\3DWLHQWV
'HILQLQJDQG7UDFNLQJ&ULWLFDO9DOXHVDWWKH+RVSLWDO/HYHO
,PSURYLQJ2UJDQL]DWLRQDO&XOWXUHZLWKLQ\RXU/DERUDWRU\
4&7HVWLQJ6FKHGXOH6WUDWHJ\
0DNLQJ1636:RUNIRU<RX
$)'HSOR\PHQWZLWK1DY\LQ6XSSRUWRI3DUWQHUVKLSIRUWKH$PHULFDV
-XVWLQ7LPH7UDLQLQJIRU'HSOR\LQJ5HVHUYLVWV
%LRORJLFDO'HWHFWLRQ0LOLWDU\&LYLOLDQ,QLWLDWLYHV
7KH6PDUW/HLVK,Q9LWUR'LDJQRVWLF'HYLFH)URP%HQFKWRSWR0DUNHW
3UHVHQWHG%\
%ULQNOH\$OGRXV
/D5RZH1HOVRQ3DXO
&KLFNHU\
/XQD
(YDQV
&XWWHU
-DFNVRQ
0DOGRQDGR
+HQGULFNV
0XUUD\
.HRZQ%ULGHQ.RKOHU
1HOVRQ0RQD
*RODVK
*RODVK
.HHQ
5HHVH
/LYLQJVWRQH
+HDWK
$OGRXV
(VFDPLOOD
4DEDU
6DUWRUL
0HODQVRQ
9LQOXDQ
0XUUD\
/HQQRQ
+DXJH
-HQNLQV&XUWLV
%HUJJUHQ
.RS\GORZVNL
3LHUVRQ
&ODUN
'H/RQJ+LOO/RQJ
6ZDUW]
7D\ORU
0LQWRQ
6WHUOLQJ
)RVWHU
3D\WRQ
+RXVH
+RFKEHUJ
SAFMLS 2008 SHORT TOPICS “AT-A-GLANCE”
6WDUW7LPH
Society Scope
Society Scope
2008 SAFMLS POSTERS
Note: Due to space constraints, some of the posters listed herein may not be presented at the annual meeting.
The BOD and Planning Committee apologize for any inconvenience.
CLINICAL
C-1: Can Efficacy of Chemical Decontamination Treatment on Dental Unit Water Lines
Major Eric Olsen1*, Major Roy Marlow1, Lt Colonel William Dunn1, Colonel Shannon Mills2, and Mr. Richard Karpay3
1
Wilford Hall Medical Center, 59th Medical Wing, Lackland AFB, TX; 2HQ USAF/SGD; 3University of Texas Health Sciences Center
Dental School, San Antonio, TX
C-2: Effect of Time, Storage Temperature, and Repeated Freezing and Thawing on Human Erythrocyte
Cholinesterase
Nizamettin Gul, Michael E. Meredith, Ho W. Lee1, Donna H. Goodman1, Robyn B. Lee
United States Army Center for Health Promotion and Preventative Medicine, Aberdeen Proving Ground, MD
C-3: Bioterrorism: Threats, Preparedness, and Response
CPT Tapo Banerjee
Tripler Army Medical Center-Hawaii
C-4: DoD Public Health Laboratory Services Internet-Accessible Databases
V. F. Kalasinsky 1, J. O. Tristan1, S.L. Strausborger1, L. Blubaugh1, L. Burry1 J. C. Gaydos2, LtCol V. H. MacIntosh2, MAJ D.S.
Johnston3, F.G. Mullick1
1
Department of Environmental and Toxicologic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306; 2U.S.
Department of Defense Global Emerging Infections Surveillance and Response System, The Walter Reed Army Institute of Research,
Silver Spring, MD 20910; 3U.S. Army Center for Health Promotion and Preventative Medicine, Aberdeen Proving Ground, MD
21010-5403
C-5: Detection of Norwalk Virus in Clinical Specimens
TSgt Leslie K. Guillermo, USAF, SSgt Anthony M. Lowman, USAF, Maj Thomas F. Gibbons, BSC, USAF, Capt Lori E. Henrichs,
BSC, USAF, Jason Garner
Brooks City-Base, TX 78235-5132
C-6: Detection of Adenovirus 14 in Clinical Specimens and Isolates
TSgt Leslie K. Guillermo, USAF, SSgt Anthony M. Lowman, USAF, Maj Thomas F. Gibbons, BSC, USAF, Capt Lori E. Henrichs,
BSC, USAF, Jason Garner
Brooks City-Base, TX 78235-5132
C-7: Mefloquine Analogs as Antimalarial Drugs; A Look at Oxazolidine Analogs their Synthesis,
Biological Activity and Instability
CPT William F. McCalmont, WRAIR, USA; SPC Duane Goodine, SPC Jose Cobar, WRAIR, USA WRAIR, USA; CPT Tiffany N.
Heady, Ft Meade, USA; Dr Jason C. Sousa, WRAIR; Dr. Erin Milner, WRAIR; MAJ Victor Melendez, WRAIR, USA; Dr. Geoffrey
Dow, WRAIR
C-8: Troponin-I Comparison Study Using the Vitros® ECI, Abbott i-STAT® and Nanogen Cardiac
STATus® Kit.
SSgt Kai Kraft, MLT(ASCP); Maj Clarence Gagni, MT(ASCP), CLS(NCA); SrA Katie Conrad, SrA Dillon DeLay, A1C Garet
Rippee, Rodrigo Pabros, CLS.
60 MDTS/SGQC, 101 Bodin Circle, David Grant USAF Medical Center, Travis AFB, CA 94535
47
Society Scope
C-9: Development of a Native Outer Membrane Vesicle Vaccine for Neisseria meningitidis Serogroup B
CPT Joseph Labrie, Mikhail Donets, Boris Ionin, Elizabeth Moran, Valerian Pinto, Deborah Schmiel, Mark Stoddard, Ryan Marcus,
and Wendell Zollinger
Walter Reed Army Institute of Research, Division of Bacterial and Rickettsial Diseases, 503 Robert Grant Ave., Silver Spring, MD
20910
C-10: Characterization of a Novel Polyclonal Antibody Against the C-type Natriuretic Peptide Receptor
William R. Gower, Jr., Abdel A. Alli, and Barrett Z. McCormick
James A. Haley VA Hospital, Tampa, FL
C-11: Use of Automated Processing and Interware to Improve Laboratory Function in Hematology
CPT Kelly W. Wilhelms, MS, USA; Paula M. Mann, DAC GS-12; Eduardo Leal, DAC GS-12; LTC Richard A. Walker, MS, USA.
William Beaumont Army Medical Center
C-12: Use of the Cellavision Dm96 to Automate the Manual Differential in the Core Laboratory
CPT Kelly W. Wilhelms, MS, USA; Paula M. Mann, DAC GS-12; Jill J. Gaines, DAC GS-11; LTC Richard A. Walker, MS, USA.
William Beaumont Army Medical Center
C-13: An Evaluation of the AdvanDx S. aureus/CNS PNA FISH™ Staphylococcus aureus/Coagulasenegative staphylococci Culture Identification Kit.
Yadira Encina, YH-02, USAF, Rachel Tapia, YH-02, USAF, Donna Hensley, YH-02, USAF.
59th Medical Wing, Lackland AFB, TX.
C-14: Characterization of Outer Membrane Vesicles in Francisella novicida
CPT Tony Pierson, MS, USA1, 2; Demetrios Matrakas1, Monique L. van Hoek1, 3
1
George Mason University, 232nd Medical Brigade, Fort Sam Houston, Texas; 3National Center for Biodefense and Infectious Diseases,
Department of Molecular and Microbiology, George Mason University, Manassas, Virginia
C-15: Characterization of Cell Death Induced by Ricin in Epithelial and Endothelial Cells
Stacy R. Rushing, CPT, USA, MS; Michelle L. Saylor; Matthew G. Baile; Martha L. Hale.
U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD.
C-16: Comparison of Methicillin Resistant Staphylococcus aureus prevalence at a Post Gymnasium and a
Staff-used Medical Center Exercise Facility
MAJ Edward Ager, Karen Fonville GS9, LTC Sandra LaFon, Miguel Alvarado GS9, SGT Christina Gomez-Bain.
William Beaumont Army Medical Center
C-17: Implementation of ImmunoCAP specific IgE testing: Potential impact for the MEDCEN Hospital
MAJ Edward Ager, Ms Yolie Thome, Ms Lydia Quinonez, LTC Richard A. Walker CPT Tony Pierson and Mr Ed Leal
William Beaumont Army Medical Center
C-18: Modernization of HIV Testing at Brooks City Base: A Total Transformation
David Escamilla, TSgt Paulina Stallcup
Brooks City Base, Texas
C-19: Adapting Multiplex Technology to Infectious Disease Testing
David Escamilla, SSgt. Gilbert Quinto
Brooks City Base, Texas
C-20: A Comparison of the Bioplex 2200 ANA Screen to Manual Methods of Autoimmune Testing
SSgt Rhonda Sullivan
Brooks City Base, Texas
48
Society Scope
C-21: Field Identification of Biological Warfare Agents: A Training and Certification Program
William Dorman, Richard Arestad, Mark Kellogg, and Mark Wolcott
United States Army Medical Research Institute for Infectious Diseases
C-22: Development and Validation of Real-Time PCR Assays for the Diagnosis of Malaria in Preparation
for FDA Clearance
CPT Jonathan D’Ambrozio, U.S. Army, MS; Dr. Jack Komisar, Ph.D; MAJ Kurt Schaecher, U.S. Army, MS; Ms. Lisa Hochberg, MS;
COL Chris Ockenhouse, U.S. Army, MC.
Walter Reed Army Institute of Research, Armed Forces Research Institute of Medical Sciences, USAMRU-Kenya, and the US Army
Medical Materiel Development Activity.
C-23: Overview of U.S. Army Malaria Drug Discovery Efforts in Support of the Warfighter
CPT Jacob D. Johnson, MSC, USA, CPT Edgie-Mark A. Co, MSC, USA, CPT Charlotte A. Lanteri, MSC, USA, Division of
Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, MD
C-24: The Efficacy of CHr and its Future Utilization as a New Part of a Complete Blood Count and RBC
Parameter in the Management of Anemia at Laboratory at David Grant Medical Center
Rodrigo Pabros1, CLS; SSgt. Ellis Harding1, Maj (Dr.) Jonathan Lopez2, Maj (Dr.)Carolyn Wild2, Capt(s) Carlos Doria1 MT(ASCP),
Maj Anthony Caruso1 MT(ASCP)
1
Clinical Laboratory, 2Hematology/Oncology Department, David Grant USAF Medical Center, Travis AFB, CA 94535
C-25: Global Profile Database to Blood Donor’s Identity, Health, Travel History
Maj Ileana Hauge, BSC; Maj Leamon K. Viveros, BSC; Maj James Benjack, BSC; Capt Anthony Polito, BSC; Richard L. Freeman,
and John J. Schlager, Ph.D.
Applied Biotechnology Branch, Human Effectiveness Directorate, Air Force Research Laboratory, Wright-Patterson AFB, Ohio
45433; 88th Diagnostic and Therapeutic Squadron/SGQC WPMC Wright Patterson Medical Center, Ohio 45433
C-26: PLATFORM EVALUATIONS IN SUPPORT OF THE JBAIDS PROGRAM
SGT Robin Payne, Catherine Baldwin, David Norwood, MAJ Jeanne Geyer
Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland
C-27: Comparison Study of ANA ELISA Screening Kits
SGT Carlos Acosta, CPT Shannon Walls, LT.COL Mark Hickman
Eisenhower Army Medical Center, Fort Gordon, GA
RESEARCH
R-1: Long-Term Stability of PCR Master Mix at Refrigerated and Room Temperatures
Major Anthony Caruso, Captain Andy Le, and Major Eric Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-2: Towards Personalized Military Training: Examination of Endurance/Performance DNAPolymorphisms
in a Cohort of AF Trainees
1Lt Jeremiah N. Betz, Dr. Victor T. Chan, SSgt Adam G. Quade, SSgt Jason J. Jacobsen, Dr. Camilla A. Mauzy
AFRL/RHPB, Wright-Patterson AFB, OH
R-3: Toxicity of Carbon and Metal Based Nanoparticles in HepG2 Cells
Richard C.T. Casabar (1), Pratibha Phadke-Gupta (1), Andrew Wallace (2), and Saber Hussain (1)
1. Air Force Research Laboratory, Wright-Patterson Air Force Base, OH, USA; 2. Department of Environmental and Molecular
Toxicology, North Carolina State University, Raleigh, NC, USA
49
Society Scope
R-4: The role of glucose energy metabolism in B lymphocyte survival responses
Richard Casabar (1), Fay J. Dufort (2), Derek Blair (2), Maria R. Gumina (2), Dean Wagner (3), Thomas C. Chiles (2)
1. Air Force Research Laboratories, RHPB, WPAFB, OH 45433; 2. Boston College, Biology Department, Chestnut Hill, MA 02467; 3.
Naval Health Research Center, Environmental Health Effects Laboratory, WPAFB, OH 45433
R-5: APPLICATION OF QUANTITATIVE PROTEOMICS TO UNDERSTANDING SULFUR
MUSTARD TOXICITY IN CELL CULTURE
CPT Patrick A. Everley, MS, USA; Dr. Albert L. Ruff; Dr. Steven P. Gygi; Dr. James F. Dillman
US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD
R-6: In Vitro Models for the Growth and Characterization of Oral Biofilms
C.A. Bell1,2, T.M. Campbell1, K.D. Gilmore1, J.J. Abercrombie1 and K.-P. Leung1
1US Army Dental and Trauma Research Detachment, Walter Reed Army Institute of Research, Great Lakes, IL, 2Current address:
DynPort Vaccine Company LLC, Frederick, MD
R-7: Novel Research Strategies for In Vitro Evaluation of Biological Interactions of Nanomaterials
Maj Ileana Hauge; Saber Hussain, Ph.D.; Kyung Yu, Ph.D.; Laura Braydich-Stolle, Ph.D.; Craig Murdock; Amanda Schrand; Nicole
Schaeublin; Kathy Szczublewski; Michael Moulton; Janice Speshock; David Mattie, Ph.D; and John Schlager, Ph.D.
Applied Biotechnology Branch, Human Effectiveness Directorate, Air Force Research Laboratory, Wright-Patterson AFB, Ohio 45433
R-8: Analysis of Recombinant Adenovirus that causes Keratoconjunctivitis
Morris Saffold Jones II, N. Ryan Hudson, Andy Le, and Don Seto
(1) Clinical Investigation Facility, David Grant USAF Medical Center, 101 Bodin Circle, Travis AFB, CA 94535, USA; (2) Bioinformatics
and Computational Biology 10900 University Blvd., MSN 5B3 Occoquan Bldg, Rm. 325 College of Science George Mason University
Manassas, VA 20110
R-9: Detection of Blastocystis from Stool Samples Using Real-Time PCR
Morris Saffold Jones II, Robert D. Ganac, Greg Hiser, N. Ryan Hudson, Andy Le, and Christopher M. Whipps
(1) Clinical Investigation Facility, David Grant USAF Medical Center, 101 Bodin Circle, Travis AFB, CA 94535, USA; (2) Department
of Microbiology, Oregon State University, Nash Hall 220, Corvallis OR 97331-3804; (3) Blastocystis Research Foundation, 5060
Philomath Blvd, #202, Corvallis, OR 97333
R-10: Blastocystis Infection is not associated with Gulf War Syndrome
Morris Saffold Jones II1, N. Ryan Hudson1, Andy Le1, Greg Hiser1, and Mike Weiner2
(1) Clinical Investigation Facility, David Grant USAF Medical Center, 101 Bodin Circle, Travis AFB, CA 94535, USA; (2) University
of California San Francisco, San Francisco, CA USA; DVA Medical Center San Francisco, VA Medical Center, 4150 Clement St, San
Francisco, CA 94121
R-11: Chronic Gastrointestinal Illness Associated with Blastocystis sp. Subtype 3 and 1
Morris Saffold Jones II, Christopher Whipps, Robert Ganac, N. Ryan Hudson, Andy Le, Greg Hiser, and Ken Boroom
(1) Clinical Investigation Facility, David Grant USAF Medical Center, 101 Bodin Circle, Travis AFB, CA 94535, USA
R-12: IN CONJUNCTION WITH DENDRITIC CELLS, IL-12 ENHANCES DENGUE SPECIFIC
IMMUNE RESPONSES
Edwin Kamau, Dupeh Palmer and Julia Lynch
Walter Reed Army Institute of Research
R-13: Flow cytometric detection and sorting of Escherichia coli using a chromosome encoded fluorescent
protein
MAJ James E. Lee
Walter Reed Army Institute of Research, Division of Bacterial and Rickettsial Diseases, 503 Robert Grant Ave., Silver Spring, MD
20906
50
Society Scope
R-14: Development of Multiple Displacement Nucleic Acid Amplification methods for Microarray
analysis of RNA Viruses
SPC Padilla S, Bode E, Kondig J, Baldwin C, SGT Payne R, SPC Gibson C, Norwood D, Maj Geyer J, Wasieloski L
Diagnostic Systems Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, USA
R-15: Rapid Bacterial Pathogen Identification With the Molecular Differential Diagnostic System
CPT Roger Price, PhD, MS, USA, Charles Guymon, MA, MAJ Clinton Murray, MD, MC, USA, Edward Horvath, DO, COL John
Holcomb, MD, MC, USA
US Army Institute of Surgical Research, FT Sam Houston, TX 78234
R-16: INHIBITION OF HEAT-SHOCK PROTEIN 90 REDUCES EBOLA VIRUS REPLICATION IN
VITRO
CPT Darci R. Smith,1 MSC, USA, John H. Connor2, Gene Olinger1, Andrea Stossel1, Joan Geisbert1, Kate Rubins3, Thomas W.
Geisbert4, and Lisa E. Hensley1
(1) U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD; (2) Department of Microbiology, Boston
University School of Medicine, Boston, MA; (3) Whitehead Institute for Biomedical Research, Boston, MA; (4) Integrated Research
Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, MD
R-17: Is there a difference in the results of high risk Human Papillomavirus testing in ASCUS cases with
the modifier “rare” compared to unselected ASCUS cases?
SGT Ivan Uscanga, ASCP (CT), LTC Michael E. Smith, M.D., LTC James F. Shikle M.D.
R-18: The SmartLeish In Vitro Diagnostic Device: From Benchtop to Market
Lisa Hochberg, Joseph Wagman, COL Russell Coleman, MS, USA, CPT Jonathon D’Ambrozio, MS, USA, George Amoo, Marshall
Van de Wyngaerde, Wayne Gilmore, LTC David Shoemaker, MS, USA, LTC Helen Viscount, MS, USA, Mr. W. Chris Gibson, Ms.
Haengcha Chong, MAJ Edward Ager, MS, USA, MAJ Steven Mahlen, MS, USA, LTC Wade Aldous, MS, USA, 1LT Brian Robinson,
MS, USA, CPT Edward Keen III, MS, Farrukh Rizvi, COL Glenn Wortmann, MC, USA, USALTC Karen Kopydlowski, MS, USA
Walter Reed Army Institute of Research, US Army Medical Materiel Development Activity, US Army Medical Research Institute of
Infectious Diseases, Brooke Amry Medical Center, Madigan Army Medical Center
R-19: A Retrospective look at the Infectivity Rate of Human Metapneumovirus in a Military Treatment
Facility
CPT Shannon Walls, MS, USA
DDEAMC, Fort Gordon GA
R-20: A Method for Development of Single Domain Antibodies for the Detection of Biothreat Agents
Mitchell W. Woodberry1, Helen Dooley2, Martin F. Flajnik2, Steve G. Lonsdale3, Randal J. Schoepp1
Diagnostic Systems Division, U. S. Army Medical Research Institute of Infectious Diseases1, Fort Detrick, Maryland, U.S.A.;
Department of Microbiology & Immunology, University of Maryland School of Medicine, Baltimore, Maryland, U.S.A.2; Dstl
Detection Department, Porton Down, Salisbury, Wiltshire, UK
R-21: Designing a Multiplex Real-Time PCR Test to be used in screening Cell Cultures for Adenovirus
SGT. DANIEL YOON, CPT. SHANNON WALLS, LTC. MARK HICKMAN
EISENHOWER ARMY MEDICAL CENTER, FT. GORDON, GA
R-22: The Structure of Genetic Diversity and the Evolutionary Processes of Dengue Viruses Circulating
in Thailand
Chunlin Zhang and Edward C. Holmes
Walter Reed Army Institute of Research and the Pennsylvania State University
51
Society Scope
R-23: FRET qPCR Assay for Listeria monocytogenes in Food and Water
Ms. Damaris Tirado, Major Anthony Caruso, Dr. J. Kevin Grayson, and Major Eric V. Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-24: FRET qPCR Assay for Campylobacter jejuni in Food and Water
Ms. Damaris Tirado, Major Anthony Caruso, Dr. J. Kevin Grayson, and Major Eric V. Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-25: FRET-qPCR Assay for Detection of Yersinia enterocolitica in Food
SSgt Mary M. Gozum, Ms. Damaris Tirado, MSgt Marianne Daughtry, Dr. J. Kevin Grayson, and Major Eric V. Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-26: FRET qPCR Shigella Assays for Food and Water
Mr. Carl Gibbins, Dr. J. Kevin Grayson, and Major Eric Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-27: FRET qPCR Detection Assay for Salmonella typhi
Mr. Carl Gibbins, Dr. J. Kevin Grayson, and Major Eric Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-28: FRET qPCR Detection of Salmonella in Food
Mr. Carl Gibbins, MSgt Marianne Daughtry, Dr. J. Kevin Grayson, and Major Eric Olsen*
Clinical Investigation Facility, David Grant Medical Center, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA
R-29: Clinical Specificity of the JBAIDS Plague and Tularemia Detection Systems
Mr. Carl Gibbins, SSgt Mary Gozum, SSgt Robert Ganac, Major Anthony Caruso, Mr. Jose Pacheco, Major Jason Lane, Captain Brian
Baker, TSgt Kristen Hess, Dr. J. Kevin Grayson, and Major Eric Olsen*
Clinical Investigation Facility (CIF), Travis AFB, CA 94535
R-30: The Impact of Collection Site on Hematologic Parameters in the Laboratory Rat (Rattus
norvegicus)
Dr. J. Kevin Grayson*, SGT Johnny Cohnes, and Mr. James Larsen
Clinical Investigation Facility, 60th Medical Group, Travis AFB, CA 94535
R-31: Optical detection of methicillin-resistant Staphylococcus aureus using lytic phage monolayers
Rajesh Guntupalli1, Iryna Sorokulova1, April Krumnow1, Oleg Pusovyy1, Eric Olsen2, and Vitaly Vodyanoy1
(1) Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849; (2)
Clinical Investigation Facility, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA 94535
R-32: Phage Fusion Proteins As Bioselective Receptors For Piezoelectric Sensors
Major Eric Olsen1*, J.C. Sykora2, I.B. Sorokulova3, I-H. Chen4, W.C. Neely2, J.M. Barbaree5, V.A. Petrenko4, and V.J. Vodyanoy3
1Clinical Investigation Facility, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA 94535; Departments of 2Chemistry and
Biochemistry; 3Anatomy, Physiology and Pharmacology, 4Pathobiology, and; 5Departments of Biological Sciences, Auburn AL
36849
R-33: Effect of the Menstrual Cycle on Pyridostigmine Bromide Acetylcholinesterase Carbamylation in
Baboons (Papio cynocephalus)
Major Eric Olsen
Wilford Hall Medical Center, 59th Medical Wing, Lackland AFB, TX
52
Society Scope
R-34: Efficacy of Chemical Decontamination Treatment on Dental Unit Water Lines
Major Eric Olsen1*, Major Roy Marlow1, Lt Colonel William Dunn1, Colonel Shannon Mills2, and Mr. Richard Karpay3
1Wilford Hall Medical Center, 59th Medical Wing, Lackland AFB, TX; 2HQ USAF/SGD; 3University of Texas Health Sciences Center
Dental School, San Antonio, TX
R-35: Electrical and Mechanical Forces of Bacterial Cells Tethered at the QCM Solid-Liquid Interface
Dr. Arnold Vainrub1, Dr. Vitaly Vodyanoy1, and Major Eric Olsen2*
1Department of Anatomy, Physiology and Pharmacology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849,
2Clinical Investigation Facility, 60th Medical Group, 101 Bodin Circle, Travis AFB, CA 94535
R-36: The FDA Validation of a Real Time PCR Diagnostic Device
Joseph Wagman, COL Glenn Wortmann, MC USA, COL Russell Coleman, MS, USA, LTC David Shoemaker, MS, USA, LTC Karen
Kopydlowski, MS, USA, Marshall Van de Wyngaerde, CPT Jonathon D’Ambrozio, MS, USA, George Amoo, Wayne Gilmore, LTC
Helen Viscount, MS, USA, Mr. W. Chris Gibson, Ms. Haengcha Chong, MAJ Edward Ager, MS, USA, MAJ Steven Mahlen, MS, USA,
LTC Wade Aldous, MS, USA, 1LT Brian Robinson, MS, USA, CPT Edward Keen III, MS, USA, Farrukh Rizvi, Lisa Hochberg
Walter Reed Army Institute of Research, Brooke Army Medical Center, Madigan Army Medical Center, US Army Medical Materiel
Development Activity, US Army Medical Research Institute of Infectious Diseases
R-37: US ARMY Research Institute of Environmental Medicine: Environmental Medicine Research
Program
CPT David W. DeGroot
US Army Research Institute of Environmental Medicine, Natick, MA
R-38: The Effect of Metal Fragments on Gait Functionality in Extremity Injuries Using a Rat Peroneal
Nerve Model
CPT Darrell F. Barker, MD; COL Paul Cutting, MD; CPT Jose Pizarro-Matos, PhD;
Department of General Surgery, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-39: Expression of Osteogenesis Genes During Early Stages of Mandibular Fracture Healing in Rats
Jauwana Adams, Farhan Ayubi, Robert Rice, Esra Toussaint, Henry H. Rowshan, Mary A. Parham, Dale A. Baur, Joseph C. Wood and
Jose M. Pizarro
Dwight David Eisenhower Army Medical Center, Department of Oral and Maxillofacial Surgery, Department of General Surgery and
Department of Clinical Investigation, Fort Gordon, GA 30905.
R-40: Improved viability of Sildenafil treated rat ischemic skin flaps are due to vasodilatation properties
of Sildenafil
Jay K. Moon, Nelson Franco MD, Thomas M. Johnson, DDS, Farhan S. Ayubi, DO, Kristopher Hart, DDS, Dale A. Baur, DDS, MD,
PhD, Esra Toussaint, PhD, and Jose M. Pizarro, MS, PhD.
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-41: Angiogenesis Associated Genetic Pathway in Ischemic, Stasis, and Normal Soft Tissue following Skin
Flap Surgery
Jose M. Pizarro, MS, PhD, Thomas M. Johnson, DDS, Franco Nelson, MD, Farhan S. Ayubi, DO, Jay K. Moon, Kristopher Hart, DDS,
Dale A. Baur, DDS, MD, Raymond Vazquez, MS, MPH., PhD, Esra Toussaint, PhD.
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-42: Sildenafil Induced Down Regulation of Angiogenesis Associated Genes in Rat Skin Flaps
Nelson A. Franco, MD, Jay K. Moon, Farhan S. Ayubi, DO, Thomas M. Johnson, DDS, Kristopher Hart, DDS, Dale A. Baur, DDS, MD,
Raymond Vazquez, MS, MPH., PhD, Esra Toussaint, PhD, and Jose M. Pizarro, MS, PhD.
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
53
Society Scope
R-43: Evaluation of the Effect of Sildenafil and Vascular Endothelium Growth Factor Combination
Treatment on Skin Flap Survival in Rats
Zhuo Zhang, MD, PhD. John W. Tsai, MD, Farhan S. Auybi, DO, Kristopher L. Hart, DDS, Dale A. Baur, DDS, MD, Mary A.
Parham, DVM, Jay K. Moon, Raymond Vazquez, MS, M.Ph., Ph.D., Arthur B. Chasen, MD, Jose M. Pizarro, MS, Ph.D.
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-44: Systemic Administration of Parathyroid Hormone (PTH 1-34) Induces a Distinct Osteogenic
Genetic Profile in the Early Phases of Mandibular Fracture Healing in Rats
Esra Toussaint, Farhan Ayubi, Robert Rice, Henry H. Rowshan, Mary A. Parham, Dale A. Baur, Joseph C. Wood and Jose M. Pizarro
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-45: Comparison of Permacol, Alloderm and PTFE patch material in repair of common carotid
arteriotomy in rabbit model
John W. Tsai, M.D., Peter J. Armstrong M.D., Farhan S. Ayubi D.O., Robert D. Rice M.D., Zhou Zhang, M.D., Ph.D.
Department of General Surgery, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-46: Using a Small Bowel Submucosal Porcine Graft (Surgisis™) to Lengthen Small Bowel in a Pig
Model (Sus scrofa) of Short Bowel Syndrome
Nathan A. Carlson, MD; Arthur Chasen, MD; Augustine Chuang, PhD
Department of Clinical Investigation, Eisenhower Army Medical Center, Fort Gordon, Georgia 30905
R-47: Assessment of Cytokine Induction by the Antiviral Agent Polyiclc with a Recombinant,
Enzymatically Inactive Ricin Vaccine (RRV)
CPT Xiaolian Tan, MS, USA
54
Society Scope
55
Society Scope
56
Society Scope
57
Society Scope
58
Society Scope
SAFMLS
2008 VENDOR LIST
6$)0/69(1'25/,67
&RPSDQ\
00HGLFDO'LYLVLRQ
$ED[LV
$EERWW'LDJQRVWLFV
%RRWKV
$HVNX,QF
$),3)RUHQVLF7R[LFRORJ\
$LU)RUFH,QVWLWXWHIRU2SHUDWLRQDO+HDOWK
$LU)RUFH0HGLFDO*HQHWLFV&HQWHU
$LU)RUFH5HVHDUFK/DERUDWRU\
$)5/+(3%
$OID:DVVHUPDQQ'LVJQRVWLF
7HFKQRORJLHV
&RPSDQ\
%RRWKV
+DHPRQHWLFV&RUSRUDWLRQ
+DUG\'LDJQRVWLFV
+HOPHU
+HPDWURQL[,QF
+HQU\6FKHLQ,QF
+\FRU$Q$JLOHQW&RPSDQ\
,GDKR7HFKQRORJ\,QF
,PPXFRU,QF
,QYHUQHVV0HGLFDO3URIHVVLRQDO'LDJQRVWLFV
,5,6'LDJQRVWLFV
$0(''&HQWHUDQG6FKRRO
.H\6FLHQWLILF3URGXFWV
$PHULFDQ0HGLFDO7HFKQRORJLVWV
.RUFKHN7HFKQRORJLHV
$PHULFDQ6RFLHW\IRU&OLQLFDO3DWKRORJ\
/DERUDWRU\&RUSRUDWLRQ9LURPHG
$UOLQJWRQ6FLHQWLILF,QF$6,
/,)(6,*1
$VXUDJHQ,QF
0DFN,QIRUPDWLRQ6\VWHPV,QF
%HFNPDQ&RXOWHU,QF
0RGHUQ/DERUDWRU\6HUYLFHV
1DWLRQDO/DERUDWRU\7UDLQLQJ1HWZRUN
%HFWRQ'LFNLQVRQ
ELR0HULHX[,QF
3HGLDWUL[0HGLFDO*URXS
3KDGLD86,QF
&DUGLQDO+HDOWK
3+*7HFKQRORJLHV
&HGDU6SULQJ,QF35,086
3URGHVVH,QF
&HQWHUIRU'LVHDVH'HWHFWLRQ&''
4%&'LDJQRVWLFV
&HQWHUIRU3KOHERWRP\(GXFDWLRQ
4XHVW'LDJQRVWLFV,QFRUSRUDWHG
5HHV6FLHQWLILF&RUSRUDWLRQ
%LR5DG/DERUDWRULHV
&(51(5
&KHPSDT
5HPHO
&KLURQD1RYDUWLV%XVLQHVV
5RFKH'LDJQRVWLFV&RUSRUDWLRQ
&OLQLFDO,QYHVWLJDWLRQV)DFLOLW\
6FLHQWLILF'HYLFH/DERUDWRU\
&ROOHJHRI$PHULFDQ3DWKRORJLVWV
6(%5$
&RPPRQZHDOWK0HGLFDO/DERUDWRULHV
'LJLWDO/DE,PDJLQJ
)RUFH3URWHFWLRQ,QQRYDWLRQ
*HQHVLV%36%ORRG3URGXFW6SHFLDOWLHV
*HQ3UREH,QF
**%&RPSDQ\
*OREDO)RFXV0DUNHWLQJ'LVWULEXWLRQ
*RYHUQPHQW6FLHQWLILF6RXUFH,QF
*UHLQHU%LR2QH,QF
*ULIROV,QF
6LHPHQV0HGLFDO6ROXWLRQV'LDJQRVWLFV
6SDUWDQ%LRVFLHQFH,QF
6\VPH[
7HUXPR0HGLFDO
7KHUPR)LVKHU6FLHQWLILF
7ULQLW\%LRWHFK
7UL6HUYLFH%ORRG%DQN)HOORZVKLS:5$0&
86$$
9:5,QWHUQDWLRQDO
59
Society Scope
The Society of Armed Forces
Medical Laboratory Scientists
Constitution and Bylaws
ARTICLE I
NAME
The name of this organization shall be “The Society of Armed
Forces Medical Laboratory Scientists, Inc.,” organized under
the Non‑Stock corporation provisions of the Articles of
Incorporation of the State of Maryland.
ARTICLE II
PURPOSE AND OBJECTIVES
1. The corporation is organized exclusively for charitable,
educational and scientific purposes in relationship to the
laboratory sciences. The primary objective is that of
maintaining and enhancing high professional standards
through improved laboratory policies and technology in
support of the health care delivery systems of the Armed
Forces, Public Health Services and Veterans Administration.
2. At least one meeting (a.k.a., Annual Meeting) shall be
held annually and be dedicated to scientific and technology
discussions concerning the upgrading of laboratory
sciences and advanced methodologies, as well as laboratory
management and leadership.
3. The Board of Directors shall define and elaborate on the
above via appropriate Bylaws, subject to approval by the
voting Members.
ARTICLE III
MEMBERSHIP
1. Membership shall be open to qualified military (active
and reserve component), Public Health Service and Veteran’s
Administration personnel, and their affiliated scientists
concerned with the support of health care via laboratory
research and evaluation.
2. Membership criteria shall be established by the Board
of Directors and specified in the Bylaws. There will be no
discrimination based on sex, religion, race, color, or national
origin.
3. A Membership Committee, appointed by the President
to determine eligibility, shall review all applicants for membership. The Membership Committee will send an applicant
report to the Secretary for presentation and acceptance prior
to each Board meeting.
4. The Board of Directors will vote on all applicants for
membership with a two‑thirds majority of a quorum required
for approval.
60
ARTICLE IV
OFFICERS
1. The Officers of the Society shall be, by order of succession, President, Vice‑President, Treasurer, and Secretary. A
conscious effort should be made to effect multiple agency
representation among the Officers of the Society and under
no circumstances will the President be from the same service
for more than two consecutive terms.
2. The Officers and a President‑Elect shall be elected
annually from among the Full Members of the Society by
majority vote during the business meeting at each Annual
Meeting, with the exception of the Treasurer and Secretary,
who shall each be elected for a three-year term.
3. The Officers shall take office at the conclusion of each
Annual Meeting, and shall be responsible for the affairs of the
Society during the following year, and for the conduct of the
succeeding Annual Meeting.
4. The President shall direct the activities of the Society
and preside over the Annual Meeting. He/she shall appoint
all committee chairs. The President shall additionally serve
as a non‑voting Member of the Board of Directors during the
year following his/her term of office. The President is responsible for financial transactions if the Treasurer becomes
unable to perform these duties. The President has the authority to appoint interim Officers in the event that an Officer
cannot complete his or her term, with approval by majority
vote of the Board of Directors. The Officer would serve until an elected Officer can assume those duties.
5. The President‑Elect will serve as the Society President
the year following the term of office of the current President,
and shall serve during this interim period as a non‑voting
Member in all meetings of the Board of Directors, unless the
President‑Elect qualifies as a voting Member under Article V
of the Bylaws.
6. The Vice‑President, in the event the President is unable
to serve, shall assume all the President’s functions. The Vice
President shall serve as the Chair, Annual Meeting Planning
Committee. The Planning Committee shall plan and propose
to the Board of Directors the program for the Annual Meeting
of the Society. In the event that the Vice President cannot
serve in this role the President will appoint the Chair, Annual
Meeting Planning Committee.
7. The Treasurer shall be responsible for the financial
affairs of the Society and shall collect all money for the
Society and make all authorized disbursements on its behalf.
Society Scope
The Treasurer shall prepare an annual financial report to be
presented at the Annual Meeting. The Board of Directors
shall designate a Certified Public Accounting firm to assist
the Treasurer in maintaining appropriate financial records,
conduct audits as needed, and prepare tax returns. The
Treasurer’s account shall also be reviewed annually by
a committee of at least three Members appointed by the
President.
8. The Secretary shall keep minutes of the Annual Business
Meeting and meetings of the Board of Directors. He/she shall
be responsible for all correspondence of the Society, including
receiving new member applications. The Secretary shall
maintain and manage the membership database and generate
dues notices annually.
ARTICLE V
BOARD OF DIRECTORS
1. Voting members of the Board of Directors will consist
of the four elected Officers, Ex-Officio members, and
Members‑At‑Large.
Non‑voting members include the
President-Elect, immediate Past President, Editor of Society
Scope, Chair of the Exhibits Program, Chair, Continuing
Education, Historian, and Webmaster.
2. Two‑thirds of the voting members assigned within the
continental United States shall compose a quorum of the
Board of Directors.
ARTICLE VI
AMENDMENTS AND BYLAWS
1. This Constitution and Bylaws may be amended by
request of two‑thirds of a quorum of the Board of Directors,
and approved by two-thirds of the Members present at the
Business Meeting.
2. Any Full Member may propose Bylaws not in conflict
with the Constitution.
ARTICLE VII
BUSINESS MEETING
1. In all matters not covered by the Constitution, or subsequent Bylaws, the provisions of Robert’s Rules of Order will
apply.
2. During each Annual Society Meeting, a period of time
will be reserved for a Business Meeting during which the
business of the Society will be transacted. Attendance will be
open to all members.
3. Only Full Members may vote during Business Meetings.
ARTICLE VIII
EXPULSION OF MEMBERS
1. If it is alleged that any Member has conducted himself/
herself in a matter detrimental to the purposes and goals of
this Society, any Member may bring the fact of the case to the
attention of a Member of the Board of Directors.
2. The Member shall be given at least 60 days in which to
prepare his/her response to the allegation, after which he/she
shall be invited to appear before or present a written statement
to a quorum of the Board of Directors. If it is the opinion of
two-thirds of the quorum of the Board of Directors that the
charges have been substantiated, the matter shall be presented
at the next Business Meeting of the Society, and upon a twothirds concurring vote of the Members present, he/she shall
be expelled permanently from the organization.
ARTICLE IX
SUSPENSION OF REQUIREMENTS
1. Provisions of this Constitution, such as the required
Annual Meetings of the Society, shall be suspended during
periods of War or other National Emergency. Such suspension shall be authorized by the concurring two-thirds vote
of the Board of Directors polled by telephone or electronic
message at the request of the President of the Society. The
Secretary shall then notify the membership in writing within
30 days.
2. In such an event the President may designate three voting
members of the Board of Directors as a Board of Regents
to conduct the affairs of the Society for the duration of the
emergency.
3. Such Regents shall have all the powers and responsibilities
delegated otherwise to the Officers and Board of Directors.
They shall function by majority vote in such manner as may
seem to them most expeditious.
4. In the event of the incapacity of any Regent by death,
illness or any other unforeseen event, he/she shall be succeeded
in order of rank by one of the remaining voting members of
the Board of Directors.
BYLAWS
1. Membership shall be open to commissioned officers
and enlisted personnel of the Armed Forces, members of the
Office of Personnel Management, Public Health Service, and
Veteran’s Administration personnel, recommended by the
Board of Directors, provided the following criteria are met:
2. Membership Categories:
a. Full Members:
(1) Commissioned officers and enlisted
personnel of the active and reserve components from one
of the Uniformed Services or personnel in full employ
61
Society Scope
of the Veteran’s Administration or Office of Personnel
Management.
(2) Qualifications in one or more of the recognized
biomedical laboratory science disciplines (e.g. Biochemistry,
Laboratory
Management/Administration,
Medical
Technology, Anatomical Pathology, Clinical Pathology,
Toxicology, Microbiology, Cytology, Biomedical Research,
etc.). Such qualifications shall require a baccalaureate degree
from an accredited college/university including courses in
biological science, chemistry and mathematics. Be in good
standing professionally.
(3) Only Full Members are entitled to vote on
Society matters.
b. Associate Members:
(1) Enlisted personnel of the active and reserve
components from one of the Uniformed Services or personnel
in full employ of the Veteran’s Administration or Office of
Personnel Management.
(2) Qualifications in one or more of the
recognized biomedical laboratory science disciplines (e.g.,
Biochemistry, Laboratory Management/Administration,
Medical Technology, Histology, Clinical Pathology,
Toxicology, Microbiology, Cytology, Biomedical Research,
etc.). Such qualifications shall require an associate degree
from an accredited college/university including courses in
biological science, chemistry, and mathematics, and have
a minimum of three years of laboratory experience, or
successful completion of an official U.S. military medical
laboratory procedures training course, and have a minimum
of six years of laboratory experience.
(3) An Associate Member will be a non-voting
Member of the Society.
c. Honorary Members:
(1) Those recommended by the Board of
Directors and confirmed by a two-thirds majority vote of
Regular Members at the Annual Business Meeting (e.g.,
distinguished scientists, physicians or others associated with
laboratory medicine.)
(2) An Honorary Member will be a non-voting
Member of the Society.
d. Emeritus Members:
(1) Members, Associate Members and Honorary
Members who have retired from professional employment
because of length of service or physical disability.
(2) An Emeritus Member will retain the same
voting status as the Member had before retirement.
3. There shall be seven Members-at-Large, each elected
for a period of two years. A Member-at-Large must first be
a Full Member of the Society except where indicated below.
Six of the seven Members-at-Large shall be Commissioned
Officer Members, with not more than two members from
62
any one service. In addition, one term for each service will
expire each year. The seventh Member-at-Large will be an
Enlisted Member from any service. The Enlisted Member
may be a Full or Associate Member. If an Associate Member
is selected, he/she will have voting privileges during his/her
term on the board. Each Member-at-Large will have one
vote.
Members-at-Large shall solicit at least one article per
year per military service branch, supporting the purpose
and objectives of the Society, for publication in the Society
Scope. Members-at-Large shall engage in active advocacy
and recruiting for Society members. Members-at-Large
shall provide support to the Annual Meeting as directed by
the Planning Committee Chair. Members-at-Large will be
the first considered to fill board member roles, such as Acting Secretary at board meeting, in the event a board member is temporarily unable to participate in Society functions
(e.g., deployed). This interim appointment will be made by
the President and approved by majority vote of the Board of
Directors.
4. The Ex‑Officio members shall be the Surgeons General
Military Consultants in Laboratory Science and in Pathology
from each of the three services. The Ex‑Officio members will
have full voting privileges.
5. The Society President shall appoint or reappoint
annually the Editor, SOCIETY SCOPE who will coordinate
and publish the Society’s official publication. The Editor
shall serve as a non-voting Member of the Board of Directors.
The appointment must be approved by majority vote of
the Board of Directors. Since the SOCIETY SCOPE is a
primary source of Society information, the Editor will keep
in close communication with the Society Officers and will
be responsible for recruiting and publishing technical papers
and administrative reports to foster the Society’s professional
growth. The Editor shall serve as a non‑voting Member of the
Board of Directors and may appoint other Society members
to assist with publication (e.g., Advertising Manager). Due
to the continuity required of this office, the editor of the
SOCIETY SCOPE will not serve for a specified term length.
The number of terms served will depend on willingness to
serve and quality of service.
6. The Society President shall appoint or reappoint
annually a SAFMLS web page manager (webmaster) who
will coordinate and maintain the SAFMLS Internet web
page. The appointment must be approved by majority
vote of the Board of Directors. The Webmaster shall serve
as a non-voting Member of the Board of Directors. The
Webmaster shall stay in regular communication with Society
officers to insure current, accurate, and relevant information
is maintained on the SAFMLS web site. Due to the special
skills and continuity required for this position, the Webmaster
Society Scope
will not serve for a specified term length. The number of
terms served will depend on willingness to serve and quality
of service.
7. The Society President shall appoint or reappoint a Society Historian. The appointment must be approved by majority vote of the Board of Directors. The Historian shall
serve as a non-voting Member of the Board of Directors.
The Historian will be responsible for collecting, preserving,
and publishing historical information relating to the activities of the Society. Additionally, the Historian will maintain
a current written history of the society. To assist with the
collection of historical data, the Historian will have access
to all Society minutes and records from board and Annual
Meeting. The historian will also be responsible for ensuring that photographic records are obtained and maintained
from all Society meetings. Due to the continuity required of
this office, the Historian will not serve for a specified term
length. The number of terms served will depend on willingness to serve and quality of service.
8. The Society President shall appoint or reappoint a Chair,
Continuing Education, to be approved by majority vote of the
Board of Directors. The Chair, Continuing Education shall
serve as a non-voting Member of the Board of Directors. He
or she will ensure that the quality of continuing education
programs offered by SAFMLS meets the highest professional
education standards, and that the continuing education contact
hours offered at the SAFMLS Annual Meeting satisfy continuing education requirements for federal regulations, state
licensure, certification agencies and employers. He or she
will be the primary liaison between SAFMLS and the Professional Acknowledgment for Continuing Education (P.A.C.E)
organization (or equivalent), and will ensure that attendees
to the Annual Meeting, upon completing various educational
programs, will receive credit for approved contact hours. Due
to the continuity required of this office, the Chair, Continuing Education will not serve for a specified term length. The
number of terms served will depend on willingness to serve
and quality of service.
9. The Society President shall appoint or reappoint annually a Chair, Exhibits Program (a.k.a. Vendor Coordinator/
Site Selection Coordinator) who shall be responsible for the
Annual Meeting site selection and coordination of the Annual Meeting events to include facilities and exhibitor (vendor) participation. The appointment must be approved by
majority vote of the Board of Directors. The Chair shall
maintain all contracts dealing with the Annual Meeting and
bring those contracts to all Board of Directors meetings. The
Chair shall be a non‑voting Member of the Board and will
not serve for a specified term length. The number of terms
served will depend on willingness to serve and quality of
service. Site selections shall normally be made a minimum
of three years in advance, and approved by two‑thirds majority vote of a quorum of the Board of Directors. The President will be authorized to sign all contractual arrangements
once the Board of Directors approves the specific city, hotel,
and/or convention center.
10. The Annual Meeting shall include a commercial vendor’s
exhibit designed to bring the latest equipment, supplies, and
methodologies to the attention of the Membership.
11. The Annual Meeting and Vendor Exhibit shall be open
to non‑Member military and civilian laboratory employees.
The Board shall determine any registration fees.
12. The Society President shall appoint a Chair, Awards
Committee. The Awards Committee will normally be made
up of Ex-Officio members and the Chair appointed by the
President. The Awards Committee shall select the winners
of all the competitive awards presented at the Annual Meeting except the Distinguished Service Award for Excellence.
A committee composed of the former Presidents and chaired
by the immediate Past President selects the recipient of this
award.
13. The Board of Directors shall be empowered to transact
all business in the name of the Society. The expenditure
of money for new obligations will require a majority vote
of a quorum of the Board. Approval for new expenditures
exceeding 25 percent of the un-obligated money in the Treasury will require a two-thirds majority vote of a quorum of
the Board.
14. Special Meetings of the Board of Directors may be
called by the President of the Society or by written request
of four or more members of the Board. In order to expedite
business matters during these meetings, votes may be cast
via conference call or by E-mail.
15. In the event of inability of both the President and
Vice‑President to function as Chair, a quorum of the Board of
Directors shall designate a President pro tempore who shall
function as President.
16. Society dues shall be set by the Board of Directors, and
paid by all Members, Associate Members, and Emeritus
Members.
17. Society annual dues will be payable by 31 March of each
year. Members who are one year in arrears on 31 March will
be suspended from the Society.
18. Application for membership or for change in category of
membership shall be made on a form approved by the Board
of Directors and shall be submitted in a manner specified on
the form. The application shall be accompanied by an annual
dues payment.
63
Society Scope
Just for Fun
Guess the Unknown
Guess the rare blood group represented by the following, in as few clues as possible:
1. Inheritance is autosomal recessive. An individual must at least be a carrier in order to
have offspring with this characteristic.
2. These patients can only be transfused with blood from other individuals with the same
genotype, and there aren’t many of them around.
3. Individuals with this blood type possess anti-A, anti-B, and anti-H in their serum. There
is no agglutination with Anti-A, Anti-B, or Anti-H typing sera.
4. Confirmation testing is performed with reaction of the RBCs with a lectin derived from
Ulex europaeus. The reaction is negative.
5. Individuals with this blood type possess no H glycosyl transferase, so there is no H
enzyme activity detected in the red cells or serum.
6. This blood group is rare except in parts of India, where it was first discovered.
The unknowns described in the Fall edition of the Scope were vitamin K deficiency and vitamin A.
Credit goes to Col Tom Hayes, USAF, for developing this series of “unknowns.”
64
Society Scope
65
2
Society Scope
Visit Our WEBSITE
at
www.safmls.org
366
Society Scope
Position 2007-2008 SAFMLS Board of Directors
Rank First Name Last Name Service E-mail
President LTC Kevin McNabb USA [email protected]
Vice President CDR Larry Ciolorito USN [email protected]
Secretary CDR Chris Howe USN [email protected]
Treasurer Maj Marybeth Luna USAF [email protected]
President-Elect LtCol Brian Casleton USAF [email protected]
Past President CDR Cindy Wilkerson USN [email protected]
Army Medical
Technology
Ex-Officio COL William Boisvert USA [email protected]
Army Pathology
Ex-Officio COL Mark Brissette
USA [email protected]
Air Force Med
Technology
Ex-Officio
Col
Paul
Barnicott
USAF [email protected]
Air Force
Pathology Ex-Officio LtCol
Dale
Selby
USAF
[email protected]
Navy Medical
Technology
Ex-Officio
CDR
Larry
Ciolorito
USN
[email protected]
Navy Pathology
Ex-Officio
CDR
Dave
Larson USN [email protected]
Army
Member-at-Large CPT Gerald
Kellar
USA [email protected]
Army
Member-at-Large MAJ Paul
Mann
USA [email protected]
Air Force
Member-at-Large Capt Denise Lennon USAF [email protected]
Air Force
Member-at-Large Maj Richard Schoske USAF [email protected]
Navy
Member-at-Large LT Debra Baker USN [email protected]
Navy
Member-at-Large LT
Aaron Harding USN [email protected]
Enlisted
Member-at-Large MSgt David Beacham USAF [email protected]
Conference Director /
Site Selection LtCol Bailey Mapp USAF [email protected]
Editor,
The Society Scope Maj Jeannette Watterson USAF [email protected]
Historian LTC Danny Deuter USA [email protected]
Pace Coordinator LT Aaron
Harding
USN [email protected]
Webmaster CAPT
Michael
Finch
USN
[email protected]
67
39
4
* Fast consistent staining
* No pre-fixing of Blood Smears
* Adjustable Stain and Buffer Times
* No daily maintenance
* Small compact Size
* One Minute Process Time
* Full One Year Warranty
* Patented Electronic Eye For Precise Decolorization
* Adjustable Stain Times
* Automatic Calibration for each Sample Slide
* Automatic Cleaning Cycle
* Fits on any Counter Top
* Does not require setup by Sink
* 4-5 Minute Process Time
* Full One Year Warranty
*
*
*
*
*
*
Fast Inexpensive First Look For TB Testing
Small Compact Size
No Daily Maintenance
2 1/2 Minute Process Time
Modified Auramine O Stain and Decolorizor
Full One Year Warranty
See
you at
the
SAFMLS
Annual
Meeting
2008
in
New
Orleans!
Calender of Events
Meetings
AAAS
Boston, MA • 14-18 Feb 2008
ASM Biodefense and Energing Diseases
Research Meeting
Baltimore, MD • 24-27 Feb 2008
CLMA ThinkLab ‘08
Atlanta, GA • 29 Mar - 1 Apr 2008
SOCIETY SCOPE
P.O. Box 2549
Fairfax, VA 22031-0549
ADDRESS SERVICE REQUESTED
Society of Toxicology
Seattle, WA • 16-20 Mar 2008
Clinical Virology Symposium
Daytona Beach, FL • 27-30 Apr 2008
Executive War College
Miami, FL • 13-14 May 2008
American Society for Microbiology
Boston, MA • 1-5 Jun 2008
Future SAFMLS Meetings
2009 Reno, NV • 2010 San Diego, CA
Presorted
FIRST CLASS
U.S. POSTAGE
PAID
PERMIT #1112
MERRIFIELD, VA
www.safmls.org